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resumo 
 
 
A presente tese tem como objetivo o desenvolvimento de uma tecnologia de 
pré-concentração para uma avaliação correta da presença de marcadores de 
poluição antropogénica em águas residuais. Devido à capacidade excecional 
que os líquidos iónicos (LIs) apresentam no que respeita ao ajuste das suas 
propriedades físicas e químicas, os sistemas aquosos bifásicos (SAB) 
constituídos por LIs providenciam eficiências de extração mais elevadas e 
específicas para os mais variados compostos, e substituindo o uso de 
solventes orgânicos voláteis (SOV). Deste modo, SAB constituídos por LIs 
foram estudados e caracterizados neste trabalho como uma técnica de 
extração e concentração simultâneas. 
Numa primeira etapa, os SAB constituídos por LIs foram estudados como 
potenciais plataformas para extrair e concentrar dois fármacos geralmente 
usados como marcadores de poluição humana, nomeadamente cafeína (CAF) 
e carbamazepina (CBZ). A presença destes dois poluentes persistentes em 
concentrações reduzidas (na ordem dos μg·dm
-3
 e ng·dm
-3
, respetivamente) 
nas águas residuais não permite uma correta deteção e quantificação pelos 
equipamentos normalmente utilizados para o efeito, sem que haja uma etapa 
prévia de concentração. Contudo, os métodos de pré-concentração 
normalmente aplicados apresentam várias desvantagens, tais como um custo 
elevado, um tempo laboral moroso, taxas de recuperação irregulares e o uso 
de SOV. Assim sendo, estudou-se um SAB constituído pelo LI cloreto de 
tetrabutilamónio ([N4444]Cl) e pelo sal biodegradável citrato de potássio 
(K3[C6H5O7]) para extrair e concentrar CAF e CBZ num único passo, 
superando assim os baixos limites de deteção do equipamento analítico 
utilizado para a quantificação de marcadores de poluição humana. 
Por último, foi estudado o efeito hidrotrópico providenciado pelos LIs que se 
refletem na capacidade destes sistemas para extrair e concentrar os mais 
variados compostos. Verificou-se que o LI é responsável pelo efeito 
hidrotrópico, permitindo um aumento da solubilidade da CAF em soluções 
aquosas, e até de 4 vezes. Além disso, uma escolha adequada do LI permite 
definir um sistema específico para melhorar a solubilidade de um composto na 
fase rica em LI, garantindo portanto o desenvolvimento de uma plataforma 
para extração e concentração com elevada eficiência. 
Os SAB constituídos por LIs foram aqui demonstrados como uma técnica 
alternativa mais versátil e promissora para a extração e concentração 
simultâneas, permitindo uma monitorização adequada de compostos 
vestigiais em matrizes das águas residuais. 
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abstract 
 
The main objective of the present thesis consists on the development of an 
analytical preconcentration technology for the concomitant extraction and 
concentration of human pollution tracers from wastewater streams. Due to the 
outstanding tunable properties of ionic liquids (ILs), aqueous biphasic systems 
(ABS) composed of ILs can provide higher and more selective extraction 
efficiencies for a wide range of compounds, being thus a promising alternative 
to the volatile and hazardous organic solvents (VOCs) typically used. For that 
purpose, IL-based ABS were employed and adequately characterized as an 
one-step extraction and concentration technique.  
The applicability of IL-based ABS was verified by their potential to completely 
extract and concentrate two representative pharmaceutical pollution tracers, 
namely caffeine (CAF) and carbamazepine (CBZ), from wastewaters. The low 
concentration of these persistent pollutants (usually found in μg·dm
-3
 and 
ng·dm
-3 
levels, respectively) by conventional analytical equipment does not 
permit a proper detection and quantification without a previous concentration 
step. Preconcentration methods commonly applied are costly, time-
consuming, with irregular recoveries and make use of VOCs. In this work, the 
ABS composed of the IL tetrabutylammonium chloride ([N4444]Cl) and the salt 
potassium citrate (K3[C6H5O7]) was investigated while demonstrating to be 
able to completely extract and concentrate CAF and CBZ, in a single-step, 
overcoming thus the detection limit of the applied analytical equipment.  
Finally, the hydrotropic effect responsible for the ability of IL-based ABS to 
extract and concentrate a wide variety of compounds was also investigated.  It 
was shown that the IL rules the hydrotropic mechanism in the solubility of CAF 
in aqueous solutions, with an increase in solubility up to 4-fold. Moreover, the 
proper selection of the IL enables the design of the system that leads to a 
more enhanced solubility of a given solute in the IL-rich phase, while allowing 
a better extraction and concentration.  
IL-based ABS are a promising and more versatile technique, and are 
straightforwardly envisaged as selective extraction and concentration routes of 
target micropollutants from wastewater matrices. 
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1. General introduction  
  
 
General introduction 1 
 
3 
 
1.1.  Ionic-liquid–based aqueous biphasic systems (IL-based ABS) as one-step 
extraction and concentration technologies, for analysis of human pollution 
tracers in aquatic environments 
 
1.1.1. IL-based ABS: a new platform for extraction and concentration 
approaches 
In many biotechnological processes, downstream processing methods for the recovery of 
the final product are a key problem and represent the highest contribution in the overall process 
costs [2-3]. In 1958, Albertsson [4] revolutionized the technology of downstream processes: 
aqueous biphasic systems (ABS) came as to be more cost-effective in one-step separation, 
purification and concentration compared to other separation techniques, while preserving the 
biological activity of the final product - a main result of the high water content [3]. 
ABS fall within the liquid-liquid extraction (LLE) techniques and involve the partitioning 
of biomolecules from one aqueous phase to another [5-6]. Usually these systems are formed by 
different pairs of solutes miscible in water (polymer-polymer, polymer-salt or salt-salt), where 
above specific concentrations the system undergoes a two-phase separation [5, 7]. Because of the 
non-volatile nature of polymers and salts, these phase-forming components can be recovered and 
recycled, and are a more benign alternative to traditional liquid-liquid extraction routes which use 
hazardous volatile organic compounds (VOC) [5-6, 8]. In the last 50 years, conventional ABS 
mainly composed of polymers have been widely investigated [5, 7-19] and used to isolate and to 
purify several biological products [5, 12, 16, 19], drug compounds [10, 13-14, 17], and small 
organic molecules from complex matrices [7-9, 15, 18]. Besides, these ABS have already been 
investigated as extraction and concentration techniques [20-21]. However, these systems present 
many drawbacks: high Viscosities, high cost and require a long equilibration time to achieve the 
phases’ separation [22-23]. In 2003, Gutowski et al. [24] demonstrated that hydrophilic ionic 
liquids (IL) can form ABS when combined with an inorganic salt in aqueous media being a 
possible alternative for extraction purposes. Since the past decade, ABS composed of ILs have 
been proposed in the design of novel separation and concentration processes [24]. 
ILs belongs to the molten salts category and are composed of a large organic cation and an 
organic or inorganic anion. Due to the large differences in size and shape between the ions, ILs 
cannot easily form an ordered crystalline structure and thus remain liquid at a general temperature 
below 373 K [25]. The most commonly studied ILs are nitrogen-based, such as those composed of 
pyrrolidinium, imidazolium, piperidinium, pyridinium, or quaternary ammonium cations. Their 
general cation molecular structures are depicted in Figure 1. On the other hand, their anions can 
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range from halogens to more complex organic and fluorinated structures. Some anion molecular 
structures, as well as the corresponding hydrogen-bond basicity (β) values are presented in Table 1. 
β indicates the hydrogen-bond accepting ability of the IL anion and it is the most used parameter to 
describe important IL properties, since solute-IL and solvent-IL interactions are mainly determined 
by the anion nature [26]. Due to their ionic character, most ILs present unique characteristics, such 
as a negligible vapor pressure [27], non-flammability, high thermal and chemical stabilities, and a 
high solvation capacity [25, 27-29], either for polar or nonpolar compounds [30-32]. Thereby, 
because of these crucial properties, ILs are usually described as “green solvents”, being one of the 
main studied strategies to replace VOCs in many applications [25]. Further, the most important 
feature that has attracted both academy and industry is their aptitude as “designer solvents”. This 
designation is given due to the numerous IL cations and anions combinations [33], and thus, ILs 
with the desired physicochemical properties (for example, hydrophobicity and their recovery 
capacity) for a specific extraction can always be foreseen [34-37]. Oppose to the limited range of 
polarities afforded by VOCs, it is theoretically possible to form at least 1 million of different ILs 
[29], which enables the possible creation of versatile ABS for enhanced separation processes [25]. 
 
Figure 1. Cation molecular structures of nitrogen-based ILs. 
 
IL-based ABS present several advantages over the typical polymer-based ABS, namely a 
low Viscosity, higher thermal stability, and enhanced and tailored extraction efficiencies for a large 
number of biomolecules [33, 38]. As polymer-based ABS present a restricted difference in 
polarities between the two immiscible phases, selective extractions of similar solutes are difficult to 
attain. Due to the inherent tailoring ability of ILs, IL-based ABS cover a wider hydrophilic-
hydrophobic range and remarkable extractions and selectivities are possible to occur [39]. In this 
context, IL-based ABS meet all the requirements for an easy design and scale-up of a wide range of 
separation processes, becoming a target of high interest in concentration steps. In the last few years, 
there was an exponential growth in published articles, showing the interest by the scientific 
community on exploring these extraction processes [39], and as shown in Figure 2. IL-based ABS 
were extensively explored in the extraction of a wide range of solutes. The results gathered from 
literature are divided in main classes of partitioned solutes: alkaloids, amino acids and proteins, 
most of them with pharmacological relevance [39]. 
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Table 1. Anion molecular structures and respective hydrogen-bond basicity (β) values (decreasing order) of 
imidazolium-based ILs with the solvatochromic probe [Fe(phen)2(CN)2]ClO4 [40]. 
IL anion β Molecular structure IL anion β Molecular structure 
Chloride 0.95 Cl- Thiocyanate 0.71  
Bromide 0.87 Br-
 
Dicyanamide 0.64 
 
Acetate 0.85 
 
Trifluorometha-
nesulfonate 
0.57 
 
Methanesulfonate 0.85 
 
Tetrafluoroborate 0.55 
 
Methylsulfate 0.75 
 
Hexafluoro-
phosphate 
0.44 
 
Trifluoroacetate 0.74 
 
Bis(trifluorometha- 
nesulfonylimide) 
0.42 
 
 
 
Figure 2. Published manuscripts on “IL-based ABS” from 2003 to 2014: number of articles per year relative 
to the characterization of IL-based ABS (blue bars); number of articles reported per year on the application 
of IL-based ABS for extraction processes (red line/scale). Values based on a search on ISI Web of Knowledge 
in 26th March, 2015. The following topics were used: “aqueous biphasic systems”, “aqueous two-phase 
systems”, “ionic liquids” and “partition coefficients” and “extraction efficiencies”. 
 
Li et al. [38] reported that IL-based ABS are able to combine with analytical techniques, 
such as High Performance Liquid Chromatography (HPLC), for the extraction and identification of 
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opium alkaloids, from real matrices, with more than 90% of recovery and an enrichment factor of 
10. This combined method avoided the use of the pretreatment time-consuming step, as well as the 
use of VOCs.  
Recently, IL-based ABS shown to be an efficient extraction route and concentration 
technique for target molecules present in biological matrices [41-42]. For instance, Passos et al. 
[42] reported that ABS composed of hydrophilic ILs and the inorganic salt potassium phosphate are 
capable to completely extract and concentrate the endocrine disruptor bisphenol A (BPA), up to 
100-fold in a single-step, from biological fluids. In this way, it is possible to use IL-based ABS as a 
concentration technique for pretreatment steps in the analytical field. 
In summary, IL-based ABS are a promising alternative, while offering the possibility to 
extract and highly concentrate (with tailored ability on the extraction efficiencies) a variety of 
solutes, in a single step procedure, allowing therefore their proper identification and quantification 
by analytical techniques and in more complex (real) aqueous matrices. These possibilities open 
new horizons to implement such processes in new areas, such as in the environmental field, where 
sewage epidemiology constitutes the major problem of aquatic sources, and where methods that 
correlate good detection with an efficient risk assessment of target micropollutants on human and 
wildlife health are also very difficult to achieve [43]. 
Most of the investigated IL-based ABS are composed of inorganic salts, with high 
concentrations of salt at the salt-rich phase [24], which results in serious environmental concerns 
[44]. Taking this drawback into consideration, recent works have successfully introduced 
biodegradable and non-toxic organic salts in the composition of IL-based ABS, such as citrate- [32, 
45], tartrate- [45-46] or acetate-based [45, 47] salts. IL-based ABS with biodegradable salts have 
shown to be an optimal replacement of systems composed of inorganic salts in extraction steps 
[32], although no enrichment factors with these systems were investigated. 
In a more recent work [48], hydrophilic IL-based ABS combined with the biodegradable 
salt potassium sodium tartrate were tested and optimized in order to extract and concentrate the 
synthetic hormone 17α-ethinylestradiol (EE2), which is one the most prominent endocrine 
disrupting compounds EDC found in wastewater treatment plant WWTP effluents and aquatic 
environments. After the complete extraction of EE2 obtained by these systems, the concentration 
factor of EE2 was further optimized, and it was found that it is possible to increase the EE2 
concentration from wastewater samples at least up to 1000-fold in a single-step [48]. These IL-
based ABS were coupled to HPLC as the analytical method. The combined methodology allowed 
to increase the EE2 concentration by three orders of magnitude (from ng·L
-1
 to µg·L
-1
), while 
overcoming the detection limits of the conventional analytical equipment used for its quantification 
[48]. 
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1.1.2. Development of a new technology 
Given that IL-based ABS already showed to be of high value to concentrate EE2 from 
WWTPs [48], a more consistent and advanced technology can be enVisaged to be applied for 
human pollution tracers (present in low amounts in aqueous samples). To this end, the development 
of a preconcentration technology for sample preparation based on ABS composed of hydrophilic 
ILs and conventional salts as salting-out agents will be investigated.  
Before the use of this technology, as both an extraction and concentration technique, the 
corresponding ABS ternary phase diagrams must be accurately determined aiming at establishing 
the biphasic region. Figure 3 represents a ternary system phase diagram composed of IL + Salt + 
H2O. A ternary phase diagram (as can be seen in the left image of Figure 3) consists of a binodal or 
solubility curve, that separates the monophasic region (MR) from the biphasic region (BR), and 
depends on certain conditions (such as pH and temperature) [49]. The knowledge of the biphasic 
region, the initial mixture composition of the ABS, and the composition of the individual phases is 
crucial to any extraction process and to predict the mechanism allied to the partitioning of a solute 
between the two immiscible aqueous phases. For a given initial mixture composition, selected from 
the biphasic region, the composition of the two immiscible phases, the bottom and top phases in 
equilibrium, are represented by two extreme points, designated by nodes (A and C, respectively), 
which remain on the binodal curve [49]. The connection between these two nodes forms a well-
defined line named tie-line (TL, ABC) [49]. Different TLs lay in a phase diagram and with 
different tie-line lengths (TLL). Higher TLL values lead to higher differences between the bottom 
and top phase compositions. The manipulation of the initial compositions along the same TL 
allows to obtain liquid-liquid systems with the same composition at the coexisting phases while 
differing in the volume ratios [49] (as can be seen in the right image of Figure 3). This is the basis 
for the development of the concentration technology carried out with ABS.  
The procedure of a simultaneous extraction and concentration step, in an ABS, consists in 
the scanning of the concentration factor (CF) (Figure 3) through the compositions of an initial 
mixture along a given TL, in order to gradually decrease the volume ratio of the phase in which the 
solute (represented by gray spheres) is being extracted, in this work corresponding to the IL-rich 
phase. The decrease of the extractive phase volume leads to an increased concentration of the 
analyte. By applying the lever-arm rule, it is possible to determine the CF value corresponding to 
the mixture point composition (CF1 < CF2 < CF3). The concentration procedure is satisfied by two 
fundamental requisites: 1) to find an ABS with a TL capable of leading to the complete extraction 
and without the saturation of the extractive phase; and 2) to use a long TL (or with a proper length) 
in order to achieve CFs as high as possible. However, at least 50 wt% of water (containing the 
target analyte) in the overall system should be kept to avoid significant discrepancies in the desired 
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CF value. It should be clarified that the use of conventional salts as salting-out agents in IL-based 
ABS was already reported in the literature, and where concentration factors of 100- and 1000-fold 
have been obtained [42, 48]. For instance, no concentration investigations have been attempted 
with weaker salting-out species. This is due to the strong salting-out effect that conventional salts 
present over the other already employed salting-out species (amino acids [50-51], carbohydrates 
[52-59] and polymers [44, 60-62]), and thus, an easier separation and manipulation of the phases’ 
properties can be made as well as the acquisition of phase diagrams with longer tie-lines (TL). In 
this work, ABS composed of ILs and strong salting-out species were investigated aiming at 
simultaneously extracting and concentrating a mixture of human micropollutants. The main goal is 
to overcome the detection limits of conventional analytical equipment commonly used in the 
analysis and monitoring of complex environmental aqueous samples. 
Table 2 reviews the benefits associated to IL-based ABS when used as a concentration 
technology: sustainability, simplicity, and improvement of sensibility. The new technology will 
allow the finding of human contamination local origins, and to create relationships between local 
consumption patterns and mixture behaviors of these contaminants in aqueous matrices. It is also 
expected to create a new technology as a general pretreatment method able to be combined with 
several analytical equipments. An adequate manipulation of the IL-ABS will allow the selection of 
an adequate CF of the target analytes from real matrices so that the identification/quantification by 
several conventional analytical equipments can be easily attempted. 
  
General introduction 1 
 
9 
 
 
Figure 3. Ternary phase diagram (orthogonal representation) for a hypothetical system composed of IL + 
Salt + H2O (left image); Schematic representation of the concentration factor achievable through the variation 
of the initial mixture composition along the TL (right image); MR – monophasic region; BR – biphasic 
region; [ABC] – TL formed by nodes A and C and by initial mixture B (composition B originates the top and 
bottom phases with the composition A and B, respectively; CF(1, 2, 3) - concentration factor 1, 2 and 3 
(increasing order); IL-rich phase (), Salt-rich phase ();extracted solute (). 
 
Table 2. Benefits associated with the preconcentration technology under development in this work. 
Benefits 
Sustainability 
"Greener" alternatives to systems using VOCs 
The concentration step implies a reduction of the phase-forming components with a 
significant reduction in the overall process costs 
Simplicity Extraction and concentration achievable in a single step 
Improvement 
of 
sensibility 
It is possible to manipulate the ABS compositions allowing the selection of the 
proper CF to be applied for the monitoring of micropollutants 
The tunable properties allied to ILs allow the design of proper ABS in order to obtain 
higher accuracy in the quantification of the tracer compounds 
  
[IL]
[Salt]
B
A
C
BR
MR
CF2
CF1
CF3
BR
[Salt]
[IL]
≥ 50 
wt% H2O
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1.2.  Scope and objectives 
The main objective of this thesis consists on the development of a preconcentration 
technology for human pollution tracers from wastewater streams allowing therefore an adequate 
monitoring of their presence in different environmental matrices. For that purpose, it is essential an 
adequate characterization of the IL-based ABS as alternative preconcentration technologies, 
namely the characterization of their phase diagrams, TLs and TLLs, and on the evaluation of their 
applicability to extract and concentrate pharmaceutical tracers from real aqueous matrices. 
Pharmaceuticals are ubiquitous micropollutants since their continuous consumption and 
consequent release via human excretions in aqueous systems are inevitable. Due to their presence 
at very low concentrations and in complex mixtures, a proper risk assessment on aquatic life and 
human health must be early established. Therefore, the development of a technology that will 
improve the sensibility while allowing the quantification and the monitoring of trace pollutants in 
complex wastewater matrices is of major relevance. In recent years, the quantification of persistent 
pharmaceuticals as human pollution tracers has been a target of various studies showing great 
potential on tracking the contamination. Conventional analytical equipment do not permit the 
detection and quantification of the low levels of these human pollution tracers if a previous 
concentration step is not carried out. However, common pretreatment processes commonly applied 
are costly and time-consuming, and make use of volatile and hazardous organic solvents. In the 
first part of this work, IL-based ABS were employed as the extraction and concentration technique. 
Two pharmaceuticals, as representative of human pollution markers, namely caffeine (CAF) and 
carbamazepine (CBZ), were investigated. The systems were formed by [N4444]Cl, the strong 
salting-out salt K3[C6H5O7] and water, with the goal of finding an improved TL capable of 
completely extracting and concentrating CAF and CBZ from wastewaters, while still guaranteeing 
the development of a cost-effective technique. 
ILs have been reported in several studies as alternative solubilizing agents of 
pharmaceutical active ingredients [63-68]. It was recently reported that ILs are a novel class of 
catanionic hydrotropes responsible for the improved solvation capacity of a wide range of 
compounds [69]. In this context, the goal of the second part of this work consists on the 
investigation of the hydrotropic effect of ILs which could justify the enhanced extraction and 
concentration ability of IL-based ABS for CAF and CBZ. 
 2 
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2.1.  Pharmacological contamination in WWTP effluents – a major concern 
as a result of human excretion 
In the past few years, several studies have reported a class of emergent human source 
contaminants present in water [43, 70-72], the micropollutants. The term “micropollutant” is due to 
the presence of organic or mineral compounds in the aquatic environment at very low 
concentrations, in the order of ng·dm
-3
 to μg·dm-3 [70, 73]. Even at those levels, these compounds 
have been investigated to display toxic, persistent and bioaccumulative properties, particularly 
when present as components of complex mixtures [70, 73]. Within the micropollutants group, 
pharmaceutical compounds are largely consumed by humans around the world [74-78]. Only in 
industrialized countries, the consumption of pharmaceuticals per year is estimated to be from 50 to 
150g per capita [79]. Despite the first report in 1960 referring the inability of WWTPs to remove 
some pharmaceuticals [80], only after 1990 they have gained a significant international concern on 
an environmental basis [81]. A large diversity of pharmaceuticals has been found in the 
environment, such as analgesics, antibiotics, antiepileptics, β-blockers, blood-lipid regulators, 
antidepressants, anxiolytics, sedatives, and contraceptives [82].  
The human excretion of pharmaceutical compounds is considered the most relevant source 
of micropollutants in WWTPs, when compared with the other disposal forms, because these 
excreted compounds can be as high as 75% of a single dose [83]. Most pharmaceuticals have a high 
solubility in aqueous matrices and do not evaporate at ambient pressure and temperature [79]. 
Moreover, they are usually resistant to degradation (as a result of their design to display a high 
durability and to be easily absorbed by the organism) [79]. Consequently, these compounds are 
actually ubiquitous contaminants through worldwide wastewater effluents [70]. Recent advances in 
analytical methods confirmed the worldwide presence of pharmaceuticals in WWTP effluents, 
surface waters, groundwaters and drinking waters [84-89]. Nevertheless, their environmental 
impact is not easy to know since the concentration of pharmaceuticals found in water supplies is 
millions of times lower than a medical dose [83]. Conventional water treatment processes do not 
have specific infrastructures to efficiently remove these “micro” compounds, as they have largely 
different physical and chemical properties [71, 90-92]. Studies have demonstrated that additional 
advanced treatment technologies are effective in removing pharmaceuticals, but they depend on the 
chemical class of the contaminants [78, 93-94]. Several studies have reported that these compounds 
do not occur individually but as complex mixtures with potential toxicity to a large variety of 
organisms, mainly due to their combined and synergistic effects [94-101], and because these 
compounds are designed and produced to therapeutically interact with cellular receptors at low 
concentrations [102-103]. Furthermore, other studies over the world have revealed that the type and 
abundance of pharmaceuticals found in water is strictly related with the local consumption 
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behavior [83]. It thus essential to determine excretion patterns of mixtures of these compounds and 
other micropollutants, like EDCs, discharged into aquatic environments, and that could pose 
considerable health risks to humans and ecological systems [83, 85]. In this way, a more defined 
degradability and environmental persistence profiles can be established, to further understand the 
chronic and acute exposure of these compounds to living organisms.  
From the mentioned above, a proper analytical methodology for the monitoring of these 
mixtures of compounds should be implemented in WWTPs, because it will give the opportunity to 
select the proper treatment processes and to ascertain on the risk assessment through the aquatic 
environment and public health [94]. There are three important reasons why some legislation 
focuses on WWTPs as central points for pollution monitoring. The first is that WWTP effluents 
continuous release pharmaceuticals and are the major source of aquatic environmental 
contamination [94]. The second reason is that the concentrations of pharmaceuticals reported in 
surface waters sources are much lower than their levels in the associated wastewater effluents. This 
feature results in a series of factors that have to be taken into account during the analytical process 
regarding the evaluation of the environmental impact of these compounds: 1) mass flow of 
contaminants [87]; 2) level of dilution at the discharging point [104]; and 3) biotransformation, 
chemical transformation, phototransformation, and sorption ability (which control the fate and 
exposure of these compounds and resulting metabolites to human and wildlife health [105-107]). 
The last reason is due to the fact that pharmaceuticals are never completely metabolized by the 
human body, resulting in the excretion through feces and urine of the unchanged parent form and 
its metabolites [108]. Once in WWTPs, the inherent presence of the fecal bacteria Escherichia coli 
deconjugates the metabolites, increasing thus the amount of the parent compounds in wastewaters 
[109-110]. 
 
2.2.  Caffeine (CAF) and carbamazepine (CBZ) as model human pollution 
tracers 
In 1997, it was suggested that by tracing the  contaminants present in water it could be 
possible to identify human activities [111]. The application of persistent pharmaceutical 
compounds as markers of anthropogenic contamination has permitted to quickly and accurately 
track the source, fate and type of aquatic contamination in natural waters [74, 77, 87, 112-113]. The 
selection of the best compounds as indicators of human pollution in aquatic systems must reflect 
their solubility in water [114], environmental significance, occurrence, resistance to treatment, and 
environmental persistence [87, 114]. The pharmacological micropollutants caffeine (CAF) and 
carbamazepine (CBZ) have been amongst the largest reported anthropogenic markers in the world 
[84, 115-120].  
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CAF, 1,3,7-trimethylpurine-2,6-dione, is an alkaloid with natural occurrence in a wide 
variety of plants [121]. It is one of the major ingredients in some food and beverages (soft and 
energetic drinks) and is also used as a pharmacological agent. CAF is the most consumed alkaloid 
in the world since it acts as a central nervous system stimulant, while increasing alertness [122]. 
The physicochemical properties of CAF and respective molecular structure are reported in Table 3. 
Its high water solubility (and small octanol-water partition coefficient, KOW) confers to CAF a high 
solubility in aqueous streams. Besides its continuous consumption and consequent discharge by 
humans at considerable values in WWTPs, it presents relative low stability under environmental 
conditions, high mobility in water, and negligible volatility [123-124]. Consequently, the 
environmental occurrence of CAF appears amongst the higher levels of detected compounds in 
incorrect discharged WWTPs effluents around the world [87]. 
 
Table 3. Physicochemical properties of CAF [1, 122, 125-127] and CBZ [1, 122, 128]. 
Properties CAF CBZ 
Molecular formula C8H10N4O2 C15H12N2O 
Molecular weight (g·mol
-1
) 194.19 236.27 
Vapor pressure at 298 K  
(mmHg) 
7.3×10-09 1.84×10-07 
Solubility in water at 298 K 
(g·dm
-3
) 
21.60 0.017 
logKOW -0.07 2.45 
pKa at 298 K 3.12 – 8.02 13.94 
Relative chemical stability Lower Higher 
Chemical structure 
  
 
CBZ, benzol[b][1]benzazepine-11-carboxamide, is a pharmacological drug designated to 
treat and prevent epilepsy and as a mood stabilizer [94]. CBZ is one of the most prescribed drugs in 
the treatment of epilepsy and other medical conditions [84]. The physicochemical properties of 
CBZ and respective molecular structure are reported in Table 3. Its relative high stability under 
environmental conditions, and negligible volatility [123], support why this drug has a negligible 
degradation in WWTP [129], even by photobleaching treatment, and therefore is one of the most 
persistent pharmaceuticals [130]. Consequently, CBZ appears as one of the micropollutants present 
in higher levels in WWTP effluents and their discharge into aquatic environments, namely in water 
sources [92, 131] and even in treated drinking water [132-133]. 
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Table 4 presents some of the recently determined concentrations of CAF and CBZ, in 
surface waters, and in different stages of WWTPs, in different worldwide regions. From Table 4 it 
is clear the high accumulation of these two pharmaceuticals (reaching values in the order of μg·L-1). 
For these reasons, CAF has been studied as a potential anthropogenic tracer in wastewater 
contamination in surface waters [87, 123, 134], stormwater outfalls [135-136], and untreated 
wastewater [123, 137]. For example, a previous study reported that the co-presence of CAF with 
nitrate can be used as a tracer of leaching from household septic systems [138]. CBZ has also been 
proposed as a potential anthropogenic tracer of local cumulative wastewater discharges [86-87, 
139]. Furthermore, Almeida et al. [84] reported that there is a growing bioaccumulation of CBZ in 
clams and in coastal systems, where their results demonstrated the high suspected toxicological 
risks to aquatic living organisms. Indeed, this drug has the potential to cause toxic effects on non-
target organisms, and a complete trace of its toxicological risk profile is very important. CBZ has 
been reported in literature as “R52/53 harmful to aquatic organisms and may cause long term 
adverse effects in the aquatic environment” [140] (according to European legislation on the 
classification and labeling of chemicals (92/32/EEC)).  
In summary, CAF and CBZ can be used as standard human pollutant markers of great 
interest, in particular when new advanced analytical procedures to detect and quantify 
micropollutants profiles in wastewater streams from WWTPs and in aquatic environment are under 
development. 
 
Table 4. Quantification of CAF and CBZ in various stages of WWTPs of two world regions (input, after 
primary and secondary treatments, and final effluent) and in surface water. 
Compound 
Wastewater 
input (μg·dm-3) 
After primary 
treatment 
(μg·dm-3) 
After secondary 
treatment 
(μg·dm-3) 
Wastewater final 
effluent (μg·dm-3) 
Surface 
water 
(μg·dm-3) 
Ref. 
CAF 
13.05 0.7 0.43 0.39 1.02  [113] 
27.7 13.6 (----) 0.038 (----) [141] 
CBZ 
5.0 (----) (----) 2.3 4.5 [132] 
0.44 0.49 (----) 0.495 0.146 [129] 
 
2.3.  Extraction and concentration of CAF and CBZ from wastewaters 
The development of precise analytical measurement technologies for the monitoring of 
wastewater matrices remains a challenge due their complex matrices and very low concentrations 
of marker pollutants (ng·dm-3 to μg·dm-3) [114]. The application of liquid chromatographic 
methods has allowed the determination of a wide range of compounds, including pharmaceuticals, 
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and have therefore permitted a more comprehensive assessment of environmental contaminants 
[89, 142-143]. Liquid chromatography tandem mass spectrometry (LC-MS/MS) and gas 
chromatography tandem mass spectrometry (GC-MS/MS) have been selected as the techniques of 
choice for the environmental analysis in wastewater matrices, either for CAF [113] or CBZ [94, 
129]. However, these techniques present several drawbacks, turning them impracticable techniques 
for many analytical laboratories: they are based on expensive devices, require high maintenance 
costs and expertise people, and the matrix effect can interfere with the technique performance [48, 
94]. HPLC coupled with ultraviolet (UV) or fluorescence detection is a simpler and cheaper 
technique [94]. In addition, it only requires a quick pretreatment method, since the presence of 
organic matter does not interfere with the quantification, minimizing thus the matrix effect [94, 
129]. However, the sensitivity, or the lower limit of quantification of these methods depends on a 
proper pretreatment and/or concentration step [76, 94]. 
A pre-concentration step is fundamental for a precise and accurate quantification of all 
pharmaceutical compounds, since they are usually present in relative low concentrations and within 
a complex environmental sample [76, 144]. Several extraction and pre-concentration techniques 
have been developed and optimized before the quantification of CBZ in water samples, such as 
LLE [145], solid-phase extraction (SPE) [139, 146], solid-phase microextraction (SPME) [147], 
and liquid-phase microextraction (LPME) [148]. Due to the good recovery capacity, with both 
pretreatment and preconcentration purposes [76], the SPE pretreatment step has been widely 
reported as a priori concentration approach for the quantification of CAF and CBZ [76, 149-150]. 
However, all these pre-concentration methods present several disadvantages, such as: 1) they are 
time-consuming, labor-intensive and costly; 2) large use of hazardous VOCs are used ; and 3) the 
solid-phase extraction processes present some recovery problems [76]. All of these drawbacks 
indicate the need to find a more sustainable, simple and effective pre-concentration method, 
capable of pre-concentrating CAF and CBZ for their further proper detection and more sensitive 
quantification in wastewater and water samples. IL-based ABS have already been a target of 
scientific research on the extraction of pharmaceutical compounds within wastewater samples [39, 
151]. These data prove that IL-based ABS are more effective alternatives over the traditional 
extraction techniques. 
In this section, it was tested the ability of the IL [N4444]Cl combined with the organic salt 
K3[C6H5O7] (a strong salting-out inducing agent) as constituents of ABS for the simultaneous 
extraction and concentration of CAF and CBZ, in order to improve their detection via conventional 
analytical techniques, namely by HPLC with UV-Vis detection. 
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2.4.  Experimental section 
2.4.1. Chemicals 
The IL studied in this work was tetrabutylammonium chloride, [N4444]Cl, obtained from 
Sigma-Aldrich. The IL used has a stated supplier purity of at least 97 wt%. The chemical structure 
of [N4444]Cl is depicted in Figure 4. Before use, aiming at reducing the water and volatile 
compounds contents to negligible values, the IL sample was dried under constant agitation at 
vacuum and at a temperature of 323 K for a minimum of 48 h. After this procedure, the purity of 
the IL was further checked by 
1
H and 
13
C NMR spectra and confirmed to be in accordance with the 
purity given by the supplier. The potassium citrate tribasic mono-hydrated, K3[C6H5O7]·H2O, > 
99.0 wt% pure, was from Sigma-Aldrich and GPR. NMR spectra of K3[C6H5O7] were made for 
both suppliers in order to verify the purity of the salt received - cf. NMR spectra in Appendix A 
(Figures A 1 and A 2). Potassium nitrate, KNO3, > 98 wt%, was acquired from Panreac, acetic 
acid, C2H4O2, > 99.5 wt%, was supplied by Labsolve JMGS, sodium acetate, NaC2H3O2, 100 wt% 
pure, was acquired from Prolabo, and potassium chloride, KCl, > 99.5 wt%, was from Chem-Lab. 
CAF anhydrous, > 99 wt % pure, was supplied by Fluka, and CBZ anhydrous, > 99 wt%, 
was supplied by Sigma. Both tracers were used as received. 
The water employed was distilled, passed across a reverse osmosis system, and further 
treated with a Milli-Q plus 185 water purification apparatus. 
HPLC grade acetonitrile, 99 wt% pure, was from HiPerSolv Chromanorm. 
 
 
Figure 4. Chemical structure of the IL investigated: tetrabutylammonium chloride, [N4444]Cl. 
 
2.4.2. Experimental procedure 
2.4.2.1. Analytical quantification of the TL for concentration analysis 
A proper TL of the liquid–liquid aqueous biphasic systems composed of [N4444]Cl + 
K3[C6H5O7] + H2O was selected from literature [32]. Once the equation commonly applied to 
describe the binodal data is not able to correctly describe the regions of the solubility curve for high 
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IL and salt concentrations [152], the concentration of each compound in both phases of this TL was 
analytically determined. It was already reported that shorter TLs obtained by the quantification of 
all phase-forming components agree well with those obtained by the mass-balance method 
proposed by Merchuk et al. [153]. However, larger differences are observed at significantly long 
TLLs, or where the concentration of one of the phase-forming components in the initial mixture is 
very low [152]. [N4444]Cl was quantified in each phase through chloride quantification using a 
Metrohm 904 Titrando ion chloride electrode. For that, a stock aqueous solution of KCl of 1 
mol·dm-3 was prepared and diluted at appropriate concentrations (between 0.110-3 mol·dm-3 and 
10010-3 mol·dm-3) in order to determine the calibration curve. A TISAB solution (mixture of 
aqueous solutions at 0.1 mol·dm-3 of KNO3, C2H4O2, and C2H3NaO2) was prepared and added in all 
standard solutions and samples to maintain the ionic strength during the measurements. The water 
content in each phase was determined by evaporation, by means of an air oven at ∼100 °C, until a 
constant weight of the non-volatile mixture [N4444]Cl + K3[C6H5O7] was achieved. The amount of 
K3[C6H5O7] was determined by the weight difference. This process was carried out in triplicate to 
ascertain on the associated standard deviations.  
2.4.2.2. Extraction and concentration of the pharmaceuticals in the [N4444]Cl-
based ABS 
The concentration factor of CAF and CBZ along the characterized TL was evaluated by the 
preparation of ternary systems at a weight ratio (weight of water added to the system per weight of 
the IL-rich phase) of 1000-fold. Along the same TL, the composition of each phase is maintained 
while varying only the volume or weight ratio of the phases (Figure 5). 
Aqueous solutions of CAF and CBZ were prepared with a concentration of 110-2 g·dm-3 
(5.15 × 10
-5
 mol·dm
-3
 and 4.23 × 10
-5
 mol·dm
-3
, respectively). The ternary mixtures were 
vigorously stirred and left to achieve the equilibrium for at least 48 h, under controlled temperature 
using an air oven at (298 ± 1) K, as previously established [48]. This time allowed to achieve the 
complete partitioning of pharmaceuticals between the two phases. The top and bottom phases were 
carefully separated under controlled temperature, at (298 ± 1) K. 
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Figure 5. ABS formed by IL + Salt + H2O: (i) IL-rich phase; (ii) salt-rich phase. The reduced IL-rich phase 
volume is due to the increased concentration along a given TL (estimated concentration factor of ca. 1000-
fold). 
 
2.4.2.3. HPLC quantification of the extracted and concentrated 
pharmaceuticals 
CAF and CBZ were quantified using a Shimadzu High-Performance Liquid 
Chromatograph (HPLC) Prominence system equipped with a SPD-20A, UV-Vis detector. This 
device consists of a degasser DGU-20A5, a bomb LC-20AD, and a column oven CTO-10ASVP. 
An ACE
®
 C18 column-PFP (5 μm, 150 mm × 4.6 mm) connected to an ACE® 5 C18 4.6 mm i.d. 
guard column was used for the separation. The detection/quantification of CAF and CBZ was 
performed at a wavelength of 272 nm and 285 nm, respectively. Both the column and cell 
temperature were maintained at 298 K. Due to the distinct chemical properties of CAF and CBZ 
(Table 3), standard solutions of [N4444]Cl with appropriate concentration and spikes of CAF and 
CBZ of the standard solution were analyzed to optimize the flow and composition of the mobile 
phase for the quantification of CAF and CBZ. The mobile phase consisted of a water–acetonitrile 
gradient mixture, at a flow rate of 0.8 mL·min
−1
. Tables 5 and 6 report the time programming of the 
gradient elution developed for the optimization of the mobile phase for quantification of CAF and 
CBZ, respectively. Water and acetonitrile used in the mobile phase were filtered using 0.2 μm 
polyamide membrane filters from Whatman. Three samples of different concentrations of CAF and 
CBZ in the IL-rich phase were analyzed in order to determine the recovery of the pharmaceuticals 
as well as the respective standard deviations. Individual standard stock aqueous solutions of CAF 
and CBZ were prepared at appropriate concentrations (1  10-3 g·dm−3, 5.1510-6 mol·dm-3 and 
i 
ii 
ii 
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4.2310-6 mol·dm-3, respectively) in order to compare the peaks areas of the pharmaceuticals in an 
aqueous standard solution and in the IL-rich phase.  
 
Table 5. Time programming of the gradient elution optimized to quantify CAF by HPLC. Solvent A: water; 
Solvent B: acetonitrile. 
Time (min) Solvent A (v/v%) Solvent B (v/v%) Wavelength (nm) 
0 75 25 272 
2 57.5 42.5 272 
4 40 60 272 
6 40 60 272 
8 40 60 272 
10 Stops 
 
Table 6. Time programming of the gradient elution optimized to quantify CBZ by HPLC. Solvent A: water; 
Solvent B: acetonitrile. 
Time (min) Solvent A (v/v%) Solvent B (v/v%) Wavelength (nm) 
0 75 25 285 
2 57.5 42.5 285 
4 60 40 285 
6 60 40 285 
8 60 40 285 
20 Stops 
 
2.4.2.4. pH measurement 
The pH values of both the IL-rich and salt-rich phases were measured at (298 ± 1) K using 
a METTLER TOLEDO SevenMulti pH meter within an uncertainty of ± 0.02. 
 
2.5.  Results and discussion 
The aqueous biphasic system composed of [N4444]Cl + K3[C6H5O7] + H2O was selected 
here since the IL [N4444]Cl is capable to undergo phase separation in the presence of aqueous 
solutions of several salts, including the salt K3[C6H5O7] used in this work. Due to its high ability on 
undergoing liquid-liquid demixing it also allows achieving long TLs and thus high concentration 
factors [32, 42, 154]. Moreover, [N4444]Cl revealed to be one of the ILs with more ability to extract 
the most diverse biomolecules, and without saturation of the IL-rich phase [32, 42, 154]. 
Ammonium-based ILs also do not present absorption in the UV region not interfering with 
analytical methods based on UV absorption. In the studied ABS, CAF and CBZ were preferentially 
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partitioned for the IL-rich phase. The pH of the medium afforded by the salt (≈ 9) allows working 
with CAF and CBZ in their neutral form - cf. speciation curves in Appendix D (Figures D 1 and D 
2) - thus avoiding their speciation and possible electrostatic contributions. 
The main characteristic of ABS to be used as concentration platforms consists on the 
selection of a proper TL that is used to analyze and manipulate the CFs intended. The selection of 
the TL to be used in the concentration process was chosen based on data taken from the literature 
[32], and according with the criteria aforementioned in the general introduction. In this context, the 
TL with a length of ca.79 was used. As previously verified, the Merchuk equation [153] commonly 
applied to describe the binodal data is not able to correctly describe the regions of the solubility 
curve for high IL and salt concentrations [152]. Thus, with the aim to attain higher enrichment 
factors, in this work, the Merchuk equation [152] problem was firstly solved, by analytically 
determining the concentration of each compound in both phases of this TL and as described in the 
experimental section, in section 2.4.2.1. Secondly, the lever arm rule was applied, as indicated by 
Equations 1 and 2. These equations allow determining the weight percentage of each component, 
and thus it is possible to estimate the CFs intended – cf. lever arm rule application and estimated 
CF values in Appendix D – Table D 1. 
 
      
                  
                                       
                                    (1) 
 
        
                
                                       
                                  (2) 
 
where      corresponds to the weight percentage of the IL-rich phase and        corresponds 
to the weight percentage of the salt-rich phase, in the ternary system. The indexes M, IL and salt 
correspond to the mixture, IL-rich phase and salt-rich phase, respectively.  
Since the aim of this section is to concentrate aqueous samples containing pharmaceuticals 
in wastewaters, it should be taken into account that the amount of the real sample added to the 
system is the same as the amount of water required to create the initial mixture point. Thus, in this 
situation, all the CF values in this work were determined by Equation 3 taking into account the total 
amount of water added to the mixture point, where after the phase equilibrium is reached it is 
expected the complete extraction of CAF and CBZ for the IL-rich phase. 
 
   
    
 
   
                                                           (3) 
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where,     
  corresponds to the weight of water added in the mixture point of the ABS and     
corresponds to the weight of the IL-rich phase obtained after phase separation. 
In this work, the correct quantification of the TL selected was not successfully achieved, 
which led to real and experimental CF values distinct from the estimated values - cf. CF values 
obtained in Appendix D – Table D 2. Figure 6 depicts the solubility curve of the [N4444]Cl + 
K3[C6H5O7] + H2O ABS, as well as the TL selected, as determined initially by the Merchuk 
equation [152], as analytically quantified, and the expected quantified TL. 
 
 
Figure 6. Evaluation of the CF along the selected TL for concentration approaches in ABS composed of 
[N4444]Cl + K3[C6H5O7] + H2O, at 298K: , binodal curve data [32]; , TL quantified by the  Merchuk 
equation [153]; , TL analytically quantified; and , “ideally” quantified TL. According to the 
corresponding colors, 100-fold and 1000-fold correspond to the CF values ideally estimated which 
correspond to 30-fold and 53-fold, respectively, according to the experimental values obtained. ABS were 
composed of 1.44 wt% of [N4444]Cl + 49.65 wt% of K3[C6H5O7] + 48.91 wt% of  H2O for estimated CF of 
100-fold and 1.18 wt% of [N4444]Cl + 49.85 wt% of K3[C6H5O7] + 48.98 wt% of H2O for CF estimated of 
1000-fold.    
 
According to Figure 6, CFs of 100- and 1000-fold were intentioned to be evaluated in this 
work in order to prove the efficiency of IL-based ABS as a concentration platform for 
micropollutants in water samples. However, 30- and 53-fold CFs were respectively obtained. These 
values were significantly distinct from the estimated values. Moreover, these deviations increase 
along the TL, i.e., for high concentrations of IL or salt, where differences in the order of two 
decimal oscillations is enough to generate great differences in the CF values. Therefore, the 
analytical quantification of the TL is a crucial requirement to obtain the CF required. CFs of 100- 
and 1000-fold were ideally planned for this work in order to allow the concentration of CAF and 
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CBZ, from those found in the wastewaters and reported in Table 4, to values that could be 
quantified by HPLC. Since the concentration levels found of CAF and CBZ in wastewaters are in 
the order of μg·dm-3 and ng·dm-3 (Table 4), respectively, a final CF value intended in this work of 
1000-fold would increase these levels in three orders of magnitude, where a final concentration of 
1.0 10-3 g·dm-3 was established to be reached after the concentration step for the IL-rich phase. In 
the HPLC quantification, if a final concentration of the pharmaceuticals of 1 mg·L
-1
 was verified, 
their complete extraction into the IL-rich phase (that means, in the [N4444]Cl-rich phase) was 
reached as well as the CF intended. In this way, a concentration platform can be developed, 
envisaged as a more cost-effective technology, without the need to establish complex protocols for 
a proper quantification of the analytes. 
Although a significant amount of experimental work is still necessary in order to correctly 
quantify the planned TL, in this section, the experimental TL was used in order to validate the 
ability of IL-based ABS to completely extract and concentrate both pharmaceuticals in a single-
procedure and simultaneously. Thus, the CF of 53-fold obtained was used in order to improve the 
detection of CAF and CBZ in wastewaters. It should be referred that, in the following results 
regarding the CF values, volumes are considered instead of the weights of water and of the 
coexisting phases, in order to eliminate significant differences arising from the density of the IL-
rich phase and water. The density of the [N4444]Cl-rich phase density, at 25 °C and atmospheric 
pressure is 1.05 g·cm
−3
 (as experimentally verified in this work). Mixture compositions of the 
several ternary systems along the given TL were firstly prepared to extract and concentrate each 
pharmaceutical. 
The chromatograms used for the identification and quantification of CAF and CBZ, 
individually extracted and concentrated, are presented in Figure 7 - cf. chromatographic data in 
Appendix D – Table D2. The quantification was made by HPLC with UV-Vis detection. Standard 
samples with initial concentrations of 1 mg·dm
-3
 of CAF and CBZ were used in order to evaluate 
the CAF and CBZ extraction efficiencies and the concentration factor of 53-fold afforded by the 
[N4444]Cl-based ABS. As it can be seen, the peak areas of CAF (peak 1) and CBZ (peak 2) in the 
[N4444]Cl-rich phases are similar with those obtained with the standard spikes. Thus, it can be 
assumed that the complete extraction of CAF and CBZ was always attained for all the mixture 
compositions and that a CF value of approximately 53-fold was obtained. The remaining peaks in 
the chromatograms are referent to possible interferences caused by the phase-forming components 
of the ABS. Further analyses are needed in order to understand such interferences by the phase-
forming components. Based on these results, the simultaneous extraction of CAF and CBZ was 
further investigated, and using the same CF of 53. CAF and CBZ were initially introduced in the 
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same [N4444]Cl -based ABS with the same final concentration of 1.0 10
-3
 g·dm
-3
 (of each 
pharmaceutical).  
 
Figure 7. Chromatograms corresponding to the quantification of pharmaceuticals, individually extracted, in 
aqueous solutions. A) Chromatogram for the identification and quantification of CAF; B) Chromatogram for 
the identification and quantification of CBZ. Chromatograms of standard solutions of CAF and CBZ (black 
line) and chromatograms of aqueous solutions of CAF and CBZ extracted into the [N4444]Cl-rich phase (red 
line). Peaks: 1 – CAF and 2 – CBZ. The remaining peaks correspond to possible interferences caused by the 
phase-forming components of the ABS. The quantification was made by HPLC with UV-Vis detection. 
 
The chromatogram of CAF and CBZ, being simultaneously extracted, is depicted in Figure 
8 - cf. chromatographic data in Appendix D – Table D 2. Standard samples with initial 
concentrations of 1 mg·dm
-3
 of CAF and CBZ were used in order to evaluate the CAF and CBZ 
extraction efficiencies and the concentration factor of 53 afforded by the [N4444]Cl-based ABS. As 
it can be seen, the peak areas of CAF (peak 1) and CBZ (peak 2) in the [N4444]Cl-rich phases 
remain similar with those obtained with the standard spikes, revealing that the IL-rich phase is not 
saturated and that both compounds can be extracted concomitantly. The recovery results obtained 
were 91 ± 15% for CAF and 104 ± 5% for CBZ. Therefore, the concentration of CAF and CBZ in 
wastewater can be increased at least up to 53-fold, in a single-step, simply by tuning the mixture 
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point composition which decreases the IL-rich phase volume. The mixture point required to create 
this condition is: 1.18 wt% of [N4444]Cl + 49.85 wt% of K3[C6H5O7] + 48.98 wt% of H2O.  
 
Figure 8. Chromatograms corresponding to the quantification of pharmaceuticals, simultaneously extracted, 
in aqueous solutions. Chromatogram of a standard solution of CAF (red line); Chromatogram of a standard 
solution of CAF (blue line); Chromatograms of aqueous solutions of CAF and CBZ extracted into the 
[N4444]Cl-rich phase (black line). Peaks: 1 – CAF and 2 – CBZ. The remaining peaks are referent to possible 
interferences caused by the phase-forming components of the ABS. The quantification was made by HPLC 
with UV-Vis detection. 
 
Although the concentration factor desired of 1000-fold was not reached in this work, the 
studied conditions guarantee the performance of the proposed technology to completely extract and 
concentrate the two human pollution tracers simultaneously. This achievement is of high 
importance to validate the efficient operation of this technique under the established requisites. The 
LOD values of the HPLC with UV-Vis detection for CAF and CBZ range between (0.1 – 1.0)  
10
-3
 g·dm-3, for both compounds. The final concentration of CAF and CBZ achieved in this work is 
1.0  10-3 g·dm-3, starting from an initial concentration of 9.0  10-6 g·dm-3 in the system. As the 
initial concentration value is increased for a final concentration above the LOD values, the 
concentration for the quantitative analysis is improved having into account their detection by the 
analytical equipment. Despite the final concentration value is included in the LOD values range, 
the area values of the resulting peaks is four times higher than a minimum area value required to be 
well correlated with an accurate detection of the compounds. This proves that the IL-based ABS 
here studied as a preconcentration method ensure a good detection by conventional analytical 
methods, in this case by HPLC - UV-Vis, for a further and proper quantification of these 
pharmaceuticals in aqueous samples.    
In a wastewater real sample, CAF and CBZ are present in concentrations in the order of 
μg·dm−3 and ng·dm−3, respectively (Table 4). The major goal was to reach a final concentration of 
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CAF and CBZ at the IL-rich phase for which a real wastewater sample can be used. However, 
taking into account the concentrations of these two compounds in real aqueous matrices, the final 
concentration of 1.0 10-3 g·dm-3 established in this work was based in a target CF value of 1000-
fold. Since a final CF value of only ca. 53-fold was reached, instead of the intended 1000-fold 
value, this concentration value is not still enough to be accurately applied to a real wastewater 
sample (to simultaneously detect and quantify these two anthropogenic pollutant markers). 
Previous works reported enrichment factors of ca. 100-fold for CBZ from wastewater samples, 
using SPE as preconcentration method [155] and HPLC - UV-Vis as the analytical method. This 
value was higher than the concentration attained in this work; however, it should be noted that the 
conditions are different and an adequate comparison between the two concentration methods is not 
possible. As referred in the general introduction, there are reports about the ability of the IL-based 
ABS with conventional salts that proved that these systems are capable to concentrate EDCs up to 
100- [42] and 1000-fold [48]. In this work, it was possible to demonstrate the high ability of the IL-
based ABS to completely extract and concentrate two pollutant tracers, independently of the CF 
value applied. Therefore, the real problem remains on the proper quantification of the TL that was 
initially established. However, further work is ongoing in order to understand how to correctly 
quantify this TL, which is the “key” for the [N4444]Cl-based ABS to be capable of reaching the CF 
value of at least 1000-fold. Moreover, it should be noted that SPE is one of the most reported 
preconcentration methods for environmental analysis, but, as referred in Section 2.3, it presents 
several disadvantages such as the use of VOCs, it is time-consuming and leads to irregular recovery 
yields. IL-based ABS are thus a promising alternative to be applied as a preconcentration method in 
environmental analysis. With this technology it will be possible to establish the risks posed to 
human health from long-term, low level exposure to such human contaminants, as well as the 
behavior of mixtures of these compounds within the environment. 
    Finally, the economical and sustainable viability of the proposed method to detect 
micropollutants in WWTPs are ensured, due also to the use of more benign phase-forming 
components, and since the amount of IL used for aqueous biphasic system formation is inversely 
proportional to the concentration factor required; furthermore, the use of HPLC with an UV-Vis 
detector allows a simpler, cheaper and easy technique to use (compared for instance with the use of 
mass spectrometry [113, 129]). 
 
2.6.  Conclusion 
Aiming at overcoming one of the major limitations in the analysis and monitoring of 
wastewaters, a novel methodology is here proposed to concentrate CAF and CBZ by the 
application of IL-based ABS. By tuning the mixture point composition, it was possible to 
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concentrate CAF and CBZ in the IL-rich phase up to 53-fold. IL-based ABS should allow to 
increase the concentration of CAF and CBZ, simultaneously, from their levels in wastewaters 
(μg·dm-3 and ng·dm-3, respectively) up to the range (0.1 – 1.0)  10-3 g·dm-3 (correspondent to the 
HPLC with UV-Vis LOD range for CAF and CBZ, respectively). However, a CF of 1000-fold is 
required to obtain a final concentration of 1.0 10-3 g·dm-3 for direct HPLC analysis. Recovery 
percentages of 91 ± 15% and 104 ± 5% for CAF and CBZ were obtained, respectively. 
Nevertheless, more experimental work is still required at this stage to improve the CF achievable. 
After this achievement, the proper evaluation of the environmental impact of pollution tracers by 
conventional and less expensive analytical equipment can be made. Since the detection and 
quantification of a wide array of micropollutants stills are a major challenge in the analytical field, 
these systems are also straightforwardly envisaged for the simultaneous extraction and 
concentration of a plethora of other components present in wastewaters. In the future, this 
preconcentration method is envisaged to be applied in the concentration and detection of other 
“microcompounds” present in more diluted concentrations, for instance in surface waters, where 
their proper analysis stills is a main challenge. 
  
  
 
3  
 
3. The hydrotropic effect 
responsible for the extraction and 
concentration ability of IL-based 
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3.1.  Hydrotropes: their role in aqueous solutions  
Since 1916, when Carl Neuberg [156] reported for the first time the existence of substances 
that enhance the solubility in water of poor water soluble compounds, the hydrotropic phenomenon 
has gained a grown impact in industry (formulation of drugs, cleaning agents, personal care 
products, for extraction purposes, among others [69, 157-161]), being these substances defined as 
hydrotropes. Hydrotropes are a class of compounds, characterized by an amphiphilic structure with 
hydrophilic nature (Kow lower than 1.0 [162]), and demonstrated to largely enhance the solubility of 
solutes in aqueous solutions, under ambient conditions [69]. Conventional hydrotropes applied in 
industry are composed of an aromatic ring (hydrophobic part) attached to an anionic group 
(hydrophilic part), with ammonium, calcium, potassium or sodium as counter ions. Examples of 
these typical compounds are sodium benzoate and sodium xylene sulphonate [161]. Figure 9 
depicts a schematic representation of the solubility of octanoic acid in aqueous solutions of 
hydrotropes and of common surfactants [161]. The presence of the hydrotrope in aqueous media, at 
high concentrations, enabled the improvement of the solubility of octanoic acid (a very poor water 
soluble fatty acid) up to approximately four times higher than that afforded by a micellar solution. 
Contrarily to common micellar surfactants, hydrotropes present a smaller hydrophobic part. 
Therefore, they do not form micelles nor present a critical micellar concentration (CMC). However, 
the mechanism of action of these compounds is still not well understood [156]. In summary, 
hydrotropes have demonstrated a higher ability to solubilize hydrophobic compounds that are 
sparingly soluble in water over other solubilizing agents.  
 
Figure 9. Schematic representation of the solubility of octanoic acid in water in presence of two solubilizing 
agents. Adapted from reference [161]. 
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Innumerous works have been attempted addressing hydrotropes, mainly due to their 
outstanding characteristics: 1) stabilization and viscosity control of aqueous solutions [161]; 2) 
high ability to modify the liquid-liquid phase separation temperatures [161]; and 3) low toxicity, 
non-flammability and low bioaccumulation [161]. But the most attractable characteristic of these 
compounds is their ability to provide the greenest recovery of solutes, i.e., since the solubility of 
the solutes depends on the hydrotrope concentration, and therefore the addition of water will simple 
lead to the solutes precipitation [161, 163]. This phenomenon opens new horizons to discover new 
compounds with potential hydrotropic effect where more cost-effective extraction and purification 
platforms can be developed.   
 
3.2.  ILs as a new class of hydrotropes: improving the solubility of 
pharmaceuticals in water 
Taking into account their unique solvent abilities for a wide range of distinct solutes, in the 
recent years, ILs have been reported in several studies as alternative solubilizing agents [157, 159-
161]. Many of these works are centered in the pharmaceutical field, where the potential of a range 
of ILs to successfully improve the solubility of poor water soluble drugs have demonstrated new 
opportunities to design the reformulation of drugs [66-67]. For example, it has been already 
investigated the use of ILs as drug delivery vehicles through the formation of stable micro-
emulsions in order to dissolve and transdermally release poor water soluble pharmaceutical 
ingredients [164-165]. Further, imidazolium-based ILs have been target of alternative drug 
reservoirs for a controlled release or even as active pharmaceutical ingredients themselves [63-65, 
166]. The solubility of paracetamol and ibuprofen, two important pharmaceuticals, were also 
investigated in the ILs 1-butyl-3-methylimidazolium hexafluorophosphate, [C4C1im][PF6], and 1-
hexyl-3-methylimidazolium hexafluorophosphate, [C6C1im][PF6], in a wide range of temperatures 
[68]. In this study [68], both ILs demonstrated to be good solvents, where an increase in the 
temperature led to an increase in the concentration of the pharmaceutical. However, two opposite 
trends were observed for the pharmaceutical compounds, namely the solubility of ibuprofen 
follows the expected trend (water < [C4C1im][PF6] < [C6C1im][PF6]) while the solubility of 
paracetamol follows a less expected order ([C4C1im][PF6] < [C6C1im][PF6] < water) [68]. These 
results reflect that ILs could have a specific-compound ability to dissolve these compounds, having 
into account the physico-chemical properties of the solutes. Nevertheless, further studies are 
necessary in order to better understand the mechanism of action ruling the interactions between the 
target solute and ILs. 
ILs present an amphiphilic behavior similar to hydrotropes, which can be responsible for 
the solubilization/extraction of a wide number of nonpolar compounds. Figure 10 represents the 
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chemical structure of the IL 1-butyl-3-methylimidazolium trifluoromethanesulfonate, 
[C4C1im][CF3SO3], as a potential hydrotrope.  
 
Figure 10. Chemical structure of 1-butyl-3-methylimidazolium trifluoromethanesulfonate 
([C4C1im][CF3SO3]). 
 
Cláudio et al. [69] recently investigated the hydrotropic ability of ILs, in comparison with 
conventional hydrotropes, to increase the solubility of phenolic compounds. Most ILs investigated 
revealed a high hydrotropic ability able to enhance the solubility in water of vanillin and gallic acid 
up to 40-fold. The IL concentration, the IL chemical structure and the temperature showed to have 
a significant impact on the solubility of these compounds [69]. An increase on the IL concentration, 
however passing through a maximum, as well as on the temperature led to a higher hydrotropic 
ability of the IL. Either the cation or the anion showed to influence the hydrotropic effect. In 
summary, Cláudio et al. [69] demonstrated that ILs constitute a novel class of catanionic 
hydrotropes and that the use of water as antisolvent conducts to the design of novel recovery 
strategies for both the solutes and IL solvents. 
Taking into account the extraction and concentration approach proposed before using IL-
based ABS, it is fundamental to understand, on a molecular-level scenario, their high ability to 
extract the two studied pharmaceuticals and without reaching the saturation of the phase. 
Therefore, in this section, it was investigated the hydrotropic mechanism responsible for the high 
solubility and extraction of CAF and CBZ using IL-based ABS. To this end, ABS composed of 
K3[C6H5O7] and a wide range of ILs, and at different mixture compositions, were investigated for 
the extraction of CAF and CBZ. To support the results achieved, the solubility of caffeine was also 
determined in aqueous solutions of these ILs and compared with those in pure water, pure ILs, and 
aqueous solutions of K3[C6H5O7] and some common hydrotropes and salting-in inducing agents, 
such as sodium benzoate, sodium citrate and sodium thiocyanate. Different initial concentrations of 
CAF were finally added into the IL-based ABS in order to infer on the saturation of the IL-rich 
phase. 
N
+
N
Hydrophilic part
Hydrophobic part
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3.3.  Experimental section 
3.3.1. Chemicals 
The ILs studied in this work were: 1-butyl-3-methylimidazolium 
trifluoromethanesulfonate, [C4C1im][CF3SO3], 1-butyl-3-methylimidazolium thiocyanate, 
[C4C1im][SCN], 1-butyl-3-methylimidazolium methylsulfate, [C4C1im][CH3SO4], 1-butyl-3-
methylimidazolium tosylate, [C4C1im][TOS], 1-butyl-3-methylimidazolium bromide, [C4C1im]Br, 
1-butyl-3-methylimidazolium dicyanamide, [C4C1im][N(CN)2], 1-butyl-3-methylimidazolium 
chloride, [C4C1im]Cl, 1-butyl-2,3-dimethylimidazolium chloride, [C4C1C1im]Cl, 1-butyl-1-
methylpyridinium dicyanamide, [C4C1py][N(CN)2], 1-butyl-1-methylpyridinium chloride, 
[C4C1py]Cl, 1-butyl-1-methylpiperidinium chloride, [C4C1pip]Cl, 1-butyl-1-methylpyrrolidinium 
chloride, [C4C1pyr]Cl, tetrabutylammonium chloride, [N4444]Cl, tetrabutylphosphonium chloride, 
[P4444]Cl, and cholinium chloride, [N1112(OH)]Cl. The imidazolium-, pyridinium-, and pyrrolidinium-
based ILs were purchased from Iolitec. The tetrabutylphosphonium chloride was kindly offered by 
Cytec Industries Inc. The tetrabutylammonium chloride and cholinium chloride were obtained from 
Sigma-Aldrich. All ILs used have a stated supplier purity of at least 98 wt%. Before use, aiming at 
reducing the water and volatile compounds contents to negligible values, all IL samples were dried 
under constant agitation at vacuum and at a temperature of 323 K for a minimum of 48 h. After this 
procedure, the purity of each IL was further checked by 
1
H and 
13
C NMR spectra and confirmed to 
be > 98 wt%. The deuterium oxide used was acquired from Aldrich with > 99.96 % D atoms. 3-
(trimethylsilyl)propionic-2,2,3,3-d4 acid sodium salt (TSP) was from Aldrich with > 98 % D atoms. 
Sodium benzoate (Na[C7H5O2]), > 99.0 wt% pure, was supplied by Panreac, sodium thiocyanate 
(Na[SCN]), > 98.0 wt % pure, was supplied by Fluka, sodium citrate (Na3[C6H5O7]), > 98.0 wt % 
pure, was from JMGS, and potassium citrate tribasic mono-hydrated (K3[C6H5O7]·H2O), > 99.0 wt 
% pure, was from Sigma-Aldrich. NMR spectrum was made for K3[C6H5O7] in order to verify the 
purity of the salt received - cf. NMR spectrum in Appendix A (Figure A 1). All of these compounds 
were also dried before use. The chemical structures of anions and cations of all ILs and salts 
investigated are depicted in Figure 8. 
CAF anhydrous, > 99 wt% pure, was supplied by Fluka and used as received. CBZ 
anhydrous, > 99 wt%, was supplied by Sigma and used as received. 
The water employed was distilled, passed across a reverse osmosis system, and further 
treated with a Milli-Q plus 185 water purification apparatus. 
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Figure 11. Chemical structures of the anions and cations of all ILs and salts investigated. 
 
3.3.2. Experimental procedure 
3.3.2.1. Extraction of pharmaceuticals with IL-based ABS 
An aqueous solution of CAF was prepared with a 
concentration of 0.912 g·dm
-3
 (4.70 × 10
-3
 mol·dm
-3
). Due to 
its low solubility in water, in each ternary mixture and 
individual experiment, ca. 1.0 × 10
-3
 g of CBZ was added, and 
in order to guarantee the same initial concentration of the two 
pharmaceuticals in these systems (mixtures with a total of 3 g 
were prepared). Several ternary systems were prepared within 
the biphasic region of the mixture of IL + K3[C6H5O7] + 
aqueous solution of CAF with the following ILs: 
[C4C1im][CF3SO3], [C4C1im][SCN], [C4C1im][CH3SO4], 
[C4C1im]Br, [C4C1im][N(CN)2], [C4C1im]Cl, [C4C1C1im]Cl, 
Figure 12. ABS formed by  
IL + C6H5K3O7 + H2O. 
 
IL-rich 
phase 
Salt-rich 
phase 
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[C4C1py][N(CN)2], [C4C1py]Cl, [C4C1pip]Cl, [C4C1pyr]Cl, [N4444]Cl, and [P4444]Cl. In order to 
avoid discrepancies in the results, the ternary systems were prepared at constant weight fraction 
percentage of each component: 40 wt% of IL + 20 wt% of K3[C6H5O7] + 40 wt% H2O. The mixture 
compositions for each ternary system are provided in Table 7. The ternary mixtures were 
vigorously stirred and left to achieve the equilibrium for at least 12 h, (298 ± 1) K (Figure 12). 
After the separation of the top and bottom phases, the detection and quantification of the 
pharmaceuticals were carried out through UV-spectroscopy, using a Synergy|HT Microplate 
Reader, from Biotek, at a wavelength of 272 nm for CAF and 285 nm for CBZ, using 
calibration curves previously established (cf. Appendix B - Figure B 1 to Figure B 2). For the 
measurement of the respective absorbance, blank controls of each ternary system were always 
prepared to eliminate interferences caused by the IL and K3[C6H5O7]. Three samples of each 
aqueous phase were analyzed, in at least three individual systems, in order to determine the 
extraction efficiencies of pharmaceuticals and the respective standard deviations. The percentage 
extraction efficiencies of the pharmaceuticals, EEPha%, were estimated by equation 4: 
 
         
          
                         
                                        (4) 
 
where     and       are the weight of the  
IL-rich and K3[C6H5O7]-rich phases, and         and           are the concentration of each 
pharmaceutical in the IL-rich and K3[C6H5O7]-rich aqueous phases, respectively. 
 
3.3.2.2. Optimization study for the extraction of CAF 
Determination of tie-lines (TLs): The TLs were determined by a gravimetric method 
originally described by Merchuk et al. [153]. A mixture point at the biphasic region was 
gravimetrically prepared with IL + salt + water, vigorously stirred, and allowed to reach the 
equilibrium by the separation of both phases for at least 12 h at (298 ± 1) K. After the separation 
step, both top and bottom phases were weighted. Finally, each individual TL was determined by 
application of the lever-arm rule to the relationship between the top phase weight and the overall 
system composition.  
For the determination of TLs, it was used the following system of four equations (equations 
5 to 8) with four unknown variables (                                    ): 
 
                       
    –           
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                                                          (8) 
 
where the indexes M, IL and salt correspond to the mixture, IL-rich phase and salt-rich phase, 
respectively. The parameter α is the ratio among the IL–rich phase and the total mixture weight. 
The solution of the referred system gives the concentration of IL and organic salt in the top and 
bottom phases, respectively. 
The tie-line lengths (TLL) were calculated through equation 9: 
 
                                                                (9) 
 
Extraction of CAF: The ternary system [C4C1im]Br + K3[C6H5O7] + aqueous solution of 
CAF was selected for the optimization study. The influence of the tie-line length (TLL), i.e., by 
varying the initial mixture composition, was analyzed aiming at reaching the complete extraction of 
the pharmaceutical in a single-step. The initial concentration of CAF added to each system was also 
studied to infer on its saturation at the IL-rich phase. 
For the analysis of the TLL effect, the ABS were prepared at increased initial 
concentrations of the IL and salt as follows: 40 wt % of [C4C1im]Br + 20 wt % of K3[C6H5O7], 40 
wt % of [C4C1im]Br + 22.5 wt % of K3[C6H5O7], 40 wt % of [C4C1im]Br + 25 wt % of 
K3[C6H5O7], 42.5 wt % of [C4C1im]Br + 25 wt % of K3[C6H5O7], and 45 wt % of [C4C1im]Br + 25 
wt % of K3[C6H5O7]. Then, for the analysis of the initial concentration of CAF in the system, three 
aqueous solutions with decreased concentrations of CAF were prepared: 0.912 g·dm
-3
 (4.70 × 10
-3
 
mol·dm
-3
), 0.456 g·dm
-3
 (2.35 × 10
-3
 mol·dm
-3
), and 0.228 g·dm
-3
 (1.17 × 10
-3
 mol·dm
-3
). 
The mixture compositions for each ternary system are provided in Table 7. All the 
partitioning experiments were performed accordingly to the conditions described in section 3.3.2.1. 
 
3.3.2.3. Solubility of CAF in aqueous solutions 
CAF (solid solute) was added in excess amounts to each IL aqueous solution, pure 
water or pure IL and K3[C6H5O7] aqueous solution, and was then equilibrated in an air oven 
(at given temperatures (± 0.5 K)), under constant agitation, using an Eppendorf 
Thermomixer Comfort equipment. Before the solubilization study of CAF, equilibration 
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conditions were optimized and the following were established: stirring velocity of 750 rpm 
and equilibration time of at least 72 h. After the saturation was reached, all samples were 
centrifuged at the same temperature of equilibration in a Hettich Mikro 120 centrifuge during 20 
min at 4500 rpm to separate the macroscopic solid and liquid phases. After centrifugation, all 
samples were placed in an air bath equipped with a Pt 100 probe and PID controller at the 
temperature used in equilibrium assays during 2 h. Then, the samples of the liquid phase were 
carefully collected and diluted in ultra-pure water, and the amount of CAF was quantified 
through UV-spectroscopy, using a SHIMADZU UV-1700, Pharma-Spec Spectrometer, at a 
wavelength of 274 nm, using a calibration curve previously established (cf. Appendix B - 
Figure B 3). In all experiments, control samples at the same compositions, but without 
solute, were used. At least three individual samples were quantified for each mixture and 
temperature. The hydrotropy constants, KHyd, were determined using the Setschenow 
equation [167], described by equation 10: 
        
                                                                   (10) 
 
where S and S0 are, respectively, the solubility (mol·kg
-1
) of CAF in the hydrotrope aqueous 
solution and in pure water, CHyd is the concentration of hydrotrope in aqueous solution (mol·kg
-1
) 
and KHyd is the hydrotropy constant (kg
-1·mol). 
 
3.3.2.4. Solubility of CAF in IL + C6H5K3O7 + H2O ternary systems 
The ternary systems selected, in the biphasic system, for the solubility studies of CAF were 
composed of the ILs [C4C1im]Cl and [C4C1im][N(CN)2]. Various systems were prepared and 
pure CAF was added by an increased concentration in the ternary mixture, until the 
saturation of the pharmaceutical was reached: 10 g·dm
-3
 (5.2 × 10
-2
 mol·dm
-3
) for [C4C1im]Cl 
and 10 g·dm
-3
 (5.2 × 10
-2
 mol·dm
-3
),  25 g·dm
-3
 (13 × 10
-2
 mol·dm
-3
), and 50 g·dm
-3
 (26 × 10
-2
 
mol·dm
-3
) for [C4C1im][N(CN)2].The mixture compositions for each ternary system are provided in 
Table 7. All mixtures were treated according to the conditions described in section 3.3.2.1.  
For the ternary systems where the saturation of CAF was reached, a previous and 
additional procedure was realized: all samples were centrifuged at (298 ± 1) K in an 
Eppendorf Centrifuge 5804, during 30 min at 3500 rpm to separate the solid (non-solubilized CAF) 
from the liquid phase. All samples were then separated according to the conditions described above 
and the CAF at both phases was quantified. The EECAF % values were also determined using 
equation 4. 
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3.3.2.5. pH measurements 
The pH values of both the IL-rich and salt-rich phases were measured at (298 ± 1) K using 
a METTLER TOLEDO SevenMulti pH meter within an uncertainty of ± 0.02. The pH values 
obtained for each aqueous phase are provided in Table 7. 
 
3.4.  Results and discussion 
All ABS applied in this work were previously characterized and are reported in the 
literature [32]. The effects of the IL anion, the IL cation core, and number of aliphatic tails were 
initially evaluated towards the partitioning of the pharmaceuticals between the two aqueous phases. 
The experimental data of the partitioning of CAF and CBZ are reported in Appendix (cf. Appendix 
D - Table D 3). Figures 13 and 14 depict the extraction efficiencies of the two pharmaceuticals, and 
respective standard deviations, in ABS formed with different ILs, K3[C6H5O7] and H2O, as well as 
the pH values of each phase. All the partitioning experiments were carried out at a fixed initial 
mixture composition of 20 wt % of salt and 40 wt % of IL. 
 
 
Figure 13. Percentage extraction efficiencies of CAF () and CBZ (), EEPha %, in different ABS at 298 K, 
regarding the IL anion effect, and respective pH values of top () and bottom () phases. All ABS are 
composed of 20 wt% of K3[C6H5O7] + 40 wt% of IL + 40 wt% of an aqueous phase. 
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Figure 14. Percentage extraction efficiencies of CAF () and CBZ (), EEPha %, in different ABS 
at 298 K, regarding the IL cation effect (on the left side of the dashed line) and the effect of the 
number of alkyl substitutions at the imidazolium cation (on the right side of the dashed line), and 
respective pH values of top () and bottom () phases. All ABS are composed of 20 wt% of 
K3[C6H5O7] + 40 wt% of IL + 40 wt% of an aqueous phase. 
 
CAF and CBZ were mainly extracted to the IL-rich phase in all ABS, with extraction 
efficiency values higher than 95%. The experimental TLs, that means the composition of the 
phases for a given mixture point, along with their respective lengths (TLL), are reported in Table 7. 
The pH values of both phases in each ABS and for the determined TLs were measured and are also 
shown. Since the pH values of each phase range between 6.70 and 10.01, and CAF and CBZ are 
mostly present in their neutral form – cf. speciation curves in Appendix D (Figures D 1 and D 2), 
electrostatic interactions occurring between the salt or IL ions and the charged solutes are not 
important and do not contribute to the partitioning behavior observed in these systems. The pH 
values of the initial C6H5K3O7 aqueous solutions used for the determination of the ABS presented a 
pH value around 9.3. As the K3[C6H5O7] aqueous solution is not a buffer solution, the differences 
observed in the pH values of both phases are due to the concentration of the salt and the different 
ILs used as phase-forming components of ABS. However it should be noted that there is a more 
marked difference between IL- and salt-rich phases on the effect of the IL cation core due to the 
presence of lower differences between the concentration of IL in the IL-rich phase and 
concentration of salt in the salt-rich phase. 
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Table 7. Weight fraction compositions (wt %) for the TLs: IL-rich (IL) phase, the initial mixture (M) and 
salt-rich (salt) phase of the ternary systems composed of IL + K3[C6H5O7] + H2O at 298 K, and the respective 
concentrations of CAF, [CAF]IL, and CBZ, [CBZ]IL, in the IL-rich phase. 
IL 
Weight fraction composition (wt %) 
TLL 
[CAF]IL 
(mol·dm-
3) 
[CBZ]IL 
(mol·dm-
3) [IL]IL [Salt]IL pHIL [IL]M [Salt]M [IL]Salt [Salt]Salt pHSalt 
[C4C1im][CF3SO3]  84.50 1.19 8.10 40.54 18.96 1.02 34.93 8.31 90.04 0.0021 0.0052 
[C4C1im][N(CN)2]  85.81 0.62 6.70 39.81 20.12 0.31 36.87 9.00 92.87 0.0016 (---)
a 
[C4C1im][SCN]  72.91 1.16 8.24 39.57 19.94 0.00 42.23 8.00 83.68 0.0019 0.0073 
[C4C1im]Br  
62.53 2.93 8.49 39.22 20.15 2.18 48.65 8.40 74.73 0.0017 0.0068 
65.08 2.37 8.72 40.01 22.36 0.99 53.50 8.16 81.99 0.0016 (---) 
70.60 1.40 8.91 39.47 25.22 0.78 54.83 8.31 87.93 0.0010 (---) 
73.39 1.02 8.84 41.77 25.07 0.58 56.38 8.80 91.46 0.0010 (---) 
75.16 0.82 9.02 44.74 24.97 0.26 60.28 8.48 95.63 0.0011 (---) 
[C4C1im]Cl  51.10 8.22 8.41 39.34 20.05 6.69 52.86 8.15 62.97 0.0014 0.0034 
[N4444]Cl 65.08 1.76 10.01 40.06 20.07 1.44 48.32 8.00 78.85 0.0014 (---) 
[P4444]Cl 66.65 3.74 8.13 39.54 20.02 2.06 42.53 7.54 75.34 0.0015 (---) 
[C4C1pyr]Cl 54.77 4.83 9.60 40.01 19.97 4.71 56.18 7.08 71.71 0.0014 (---) 
[C4C1pip]Cl  52.77 5.69 9.39 39.73 20.06 2.39 61.23 8.16 74.99 0.0018 (---) 
[C4C1C1im]Cl  
77.89 0.23 9.11 40.20 25.27 18.76 39.13 7.25 71.58 (---) (---) 
63.56 3.17 9.19 36.35 23.24 24.15 32.24 9.12 48.98 0.0011 0.0033 
a (---) means that these values were not determined during experimental procedure 
 
According to Figure 13, the effect of the IL anion was studied using several ILs containing 
the common [C4mim]
+
 cation, while combined with the following anions: [CF3SO3]
-
, [N(CN)2]
-
, 
[SCN]
-
, Br
-
, and Cl
-
. The partitioning of CBZ is similar for all ILs studied and practically a 
complete extraction was obtained for this compound with all systems investigated: 
[C4C1im][CF3SO3] ≈ [C4C1im][SCN] ≈ [C4C1im]Br ≈ [C4C1im]Cl. This trend is in accordance with 
the higher extraction values obtained in a previous work with more hydrophobic molecules [48]. In 
fact, CBZ is a highly hydrophobic substance (logKow = 2.45 (Table 3)). On the other hand, the 
anions of imidazolium-based ILs present a more significant impact on the partitioning of CAF. The 
extraction efficiencies of CAF were lower than those observed for CBZ and decrease in the order: 
[C4C1im][N(CN)2] > [C4C1im][SCN] > [C4C1im]Cl > [C4C1im]Br > [C4C1im][CF3SO3]. This trend 
is closely related with that reported in a previous work where ABS composed of ILs and K3PO4 
were investigated [41], and where the partitioning of CAF follows the IL anion salting-in inducing 
capacity (Hofmeister-like series) [168]. In general, a more hydrated IL-rich phase, i.e., IL with 
anions with higher β values leads to higher partition coefficients and extraction efficiencies. 
However, the ABS formed by the ILs [C4C1im][SCN] and [C4C1im][N(CN)2] are outsiders to this 
trend, having achieved the highest values of EECAF%, namely 98.68 % and 99.18 %. According 
with Table 1, these two ILs present lower β values than [C4C1im]Cl and [C4C1im]Br. The low 
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log(Kow) value of CAF of -0.07 (Table 3) reflects its polarity characteristics and its low affinity for 
organic fluids. The polarity of CAF can be explained by its molecular structure, where two oxygen 
atoms are attached to a purine ring (Table 3). Indeed, water-CAF major interactions can be 
purposed as important since lower EECAF% were obtained with less hydrated IL-rich phases. The 
ABS formed by [C4C1im][CF3SO3] led to the lowest EECAF% value of 96.6%. [C4C1im][CF3SO3] is 
the most hydrophobic IL here investigated resulting in an IL-rich phase more concentrated in IL, 
and as can been seen by the TLs data shown in Table 7.  
The effect of the IL cation core was investigated with ILs containing the common Cl
-
 
anion, while combined with the following cations: [N4444]
+
, [P4444]
+
, [C4C1pyr]
+
, [C4C1pip]
+
 and 
[C4C1im]
+
. As can be seen in Figure 14 (on the left side of the dashed line), EECAF% decreases in 
the order: [N4444]Cl > [P4444]Cl > [C4C1pyr]Cl > [C4C1im]Cl > [C4C1pip]Cl. For the differences 
observed in EECAF% values, the IL cation has a higher influence through the extraction of CAF, as 
already demonstrated in previous studies [41]. In general, [N4444]Cl and [P4444]Cl present similar 
and the highest EECAF% values. It seems that the imidazolium aromaticity has a low impact on the 
extraction of CAF. The low contribution of the aromatic ring of the imidazolium cation has already 
been suggested in the extraction of CAF using IL-based ABS [121]. 
The effect of the number of alkyl substitutions at the imidazolium cation core was also 
studied with the ILs [C4C1im]Cl and [C4C1C1im]Cl. According to Figure 14 (on the right side of 
dashed line), both ILs lead to similar extraction efficiencies values for CAF and CBZ. Therefore, 
the substitution of the most acidic hydrogen at C2 of [C4C1im]Cl by an alkyl group, while reducing 
the ability of [C4C1C1im]Cl to form hydrogen-bonds with the solute, seems to have no major 
impact. This tendency clearly evidences that the hydrogen-bond interactions between the oxygen 
and nitrogen atoms of CAF and the oxygen atom of CBZ and the imidazolium cation do not play a 
significant role on the partitioning mechanism. 
In general, the effect of the IL chemical structure seems to have a more significant impact 
on the partitioning of CAF than in CBZ. In fact, the extraction efficiencies values of CAF were 
lower and more divergent than those obtained for CBZ. This difference is due to the distinct 
properties that these two pharmaceuticals present, being CAF more polar than CBZ (Table 3), 
which gives to this last compound a higher affinity to the IL-rich phase. In order to achieve the 
complete extraction of CAF into the IL-rich phase, and taking into account the major goal of ABS 
as concentration techniques for the wastewaters monitoring, further studies were conducted, 
namely on the concentration of the phase-forming components of the ABS and concentration of 
CAF added (to infer if saturation is occurring in the IL-rich phase). For that purpose, the ABS 
composed of [C4C1im]Br + K3[C6H5O7] + H2O was chosen in order to optimize the EECAF% values. 
Since using an initial mixture point of 20 wt % of salt and 40 wt % of IL. this ABS presented an 
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EECAF% = 97.56%, by increasing the mixture compositions, through a TLL increase, it is 
expectable to enhance the extraction ability of the system. In the same way, by decreasing the 
initial concentration of CAF it is possible to verify the saturation (or not) of the IL-rich phase with 
the solute. The experimental data of the partitioning of CAF along the TLL are reported in 
Appendix (cf. Appendix D - Table D 3). The experimental TLLs studied to optimize the system 
[C4C1im]Br + K3[C6H5O7] + H2O are reported in Table 7 and illustrated in Figure 15. 
 
Figure 15. Phase diagram for the ternary system composed of [C4C1im]Br + K3[C6H5O7] + H2O: binodal 
curve data (); TL data (); adjusted binodal data through Merchuk’s equation [153] ( ). 
 
Figure 16 shows the results of the effect of the TLL and of the initial concentration of CAF 
through the optimization of the CAF extraction efficiency with [C4C1im]Br-based ABS, and 
respective standard deviations. It is possible to conclude that the TLL affects the extraction ability 
of IL-based ABS for CAF. In general, an increase in the IL concentration, i.e., an increase in the 
TLL, leads to improved EECAF% values. A further increase in the TLL was not possible to 
implement for the extraction of CAF since the solid-phase equilibrium was verified thereinafter. On 
the other hand, to verify that the effect of the concentration of CAF in the system, initial 
concentrations of 0.912, 0.456, and 0.228 g·dm
-3
 were then studied in the same systems along with 
the TLL effect. In general, the increase of the concentration of CAF improves the extraction of 
CAF, meaning that the solubility characteristics of CAF in the IL-rich phase seem to be significant 
in the extraction efficiencies. Thus, at these concentrations, it seems that the saturation of the IL-
rich phase is not reached. Taking into account the data shown in Figure 16, longer TLLs lead to 
better extraction profiles, regardless of the concentration of CAF added to the system. In summary, 
longer TLLs are preferable since the compositions of the two phases are significantly more 
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different. In this context, it is essential to better understand the hydrotropic mechanism afforded by 
ILs which improve the solubility of CAF. 
 
 
Figure 16. Percentage extraction efficiencies of CAF, EECAF %, at 298 K, at different initial concentrations 
(wt % salt, wt % IL) of the ABS [C4C1im]Br + K3[C6H5O7] + H2O, and at different concentration of aqueous 
solution of CAF: 0.912 g·dm-3 (), 0.456 g·dm-3 (), and 0.228 g·dm-3 (). 
 
In this section, the ability of ILs as hydrotropes was investigated by determining the 
solubility of CAF in several aqueous solutions. For that, different concentrations of ILs were 
compared with results obtained with common hydrotropes and salting-in inducing salts. 
Furthermore, the effects of the chemical structure and temperature on the hydrotropic capacity of 
the IL were also assessed. The obtained solubility of CAF in pure water was (23.09 ± 1.36) g·dm-3, 
which corresponds to (0.12 ± 0.01) mol·dm-3, at 303 K. This value is in accordance with the values 
reported in the literature at the same temperature [169-170]. 
Figure 17 depicts the solubility of CAF at 303 K in aqueous solutions of ILs. Aqueous 
solutions of ILs with concentrations up to 2.0 molHyd·kgwater
-1
 were used. The experimental data of 
the solubility of CAF and CBZ are reported in Appendix (cf. Appendix C - Table C 1). 
In general, ILs reveal a higher hydrotropic ability compared with the conventional 
hydrotropes and salting-in inducing salts, namely Na3[C6H5O7], K3[C6H5O7], Na[SCN], and 
Na[C7H5O2]. The hydrotropy constants, KHyd, were also determined for each aqueous solution 
studied and are reported in Table 8 with the respective standard deviations. Higher KHyd values 
reflect a higher hydrotropic ability of the compound to enhance the solubility of CAF in aqueous 
medium. This capacity obeys the following order (where the ILs used in the formation of ABS for 
the extraction of CAF are highlighted in bold): Na3[C6H5O7] < K3[C6H5O7] < [N1112OH]Cl < 
[C4C1pip]Cl < [C4C1pyr]Cl < [C4C1py]Cl < [C4C1C1im]Cl < [C4C1im]Cl < [C4C1im]Br < 
[P4444]Cl < [C4C1im][CH3SO4] < [N4444]Cl < Na[SCN] < [C4C1im][SCN] < [C4C1im][N(CN)2] < 
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[C4C1im][CF3SO3] < Na[C7H5O2] < [C4C1im][TOS] < [C4C1py][N(CN)2]. It should be noted that 
the salts Na3[C6H5O7] and K3[C6H5O7], with the former used in the formation of the ABS 
investigated, display  negative KHyd values, acting thus as salting-out agents (by decreasing the 
solubility of CAF in water). The [CAF]IL values shown in Table 7 closely correlate with the 
hydrotropic ability of the IL for CAF. Higher KHyd values correspond to higher [CAF]IL values. 
Higher TLLs in the corresponding systems also correspond to higher [CAF]IL values, since an 
increase in the IL concentration in the top phase leads to an increased concentration of CAF. This 
behavior is consistent with the solubility study depicted in Figure 17 where an increase in 
hydrotrope concentration leads to an increase in KHyd. Concluding, the TLL effect seems to be 
correlated with the hydrotropic ability of IL.  
In the ABS studied above, the saturation of the phase was not verified. The KHyd values 
achieved for CAF are lower than those reported for vanillin and gallic acid [69], indicating that the 
hydrotropic effect is closely dependent on the solute properties. 
 
 
Figure 17. Influence of the hydrotropes (ionic liquids and conventional salts) concentration in the solubility 
of CAF in aqueous solutions at 303 K: pure water (---,), [C
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Taking into account the results shown in Table 8, [C4C1im]Cl is one of the compounds with 
the lowest hydrotropic ability, while [C4C1im][N(CN)2] is the IL with the highest hydrotropic 
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effect. These two ILs were further studied in order to understand their ability to solubilize CAF, 
i.e., how much these two compounds can enhance the solubility of the biomolecule.  
Figure 18 represents the influence of the IL concentration in the solubility of CAF, namely 
in aqueous solutions of [C4C1im][N(CN)2] and [C4C1im]Cl – the respective data are reported in 
Appendix (cf. Appendix C - Table C 2). The solubility was studied in a complete concentration 
range, from pure water up to aqueous saturated solutions of these compounds at 303 K. S/S0 
represents how many times the solubility is enhanced, where S and S0 represent the solubility 
(mol·kg-1) of each biomolecule in the aqueous solutions of ILs and in pure water, respectively. 
As can be seen from Figure 18, the ability of aqueous solutions of ILs to solubilize the 
alkaloid is much higher than pure water. It is possible to enhance 4 times the solubility of CAF in 
aqueous solutions of ILs when compared with pure water. However, [C4C1im]Cl has a less 
significant impact on solubilizing CAF when compared with [C4C1im][N(CN)2]. In general, the 
solubility enhanced factors obtained for CAF are significantly lower than those reported for 
vanillin and gallic acid [69]. In this case, the values of maximum enhancement factors reported 
were 40-fold for vanillin, with [C4C1im][N(CN)2], and 20-fold for acid gallic with [C4C1im]Cl [69]. 
Therefore, the hydrotropic effect is largely dependent on the nature of the target solute. CAF is a 
polar compound with higher affinity for water than for organic compounds, compared with the 
more water poor soluble vanillin and acid gallic, with log(Kow) values of 1.37 [122] and 0.70 [122], 
respectively. Thus, the increased addition of IL in aqueous solution is more significant for 
solubilizing these two biomolecules. In this line, it is expected a much higher hydrotropic 
phenomenon of ILs in respect to CBZ. 
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Table 8. KHyd values for the various hydrotropes studied in the solubility of CAF. 
Hydrotrope 
KHyd  10
3
 
(g
-1·mol) 
Na3[C6H5O7] -0.8636 
K3[C6H5O7] -0.8485 
[N1112OH]Cl -0.171 
[C4C1pip]Cl -0.0592 
[C4C1pyr]Cl -0.0469 
[C4C1py]Cl 0.07 
[C4C1C1im]Cl 0.176 
[C4C1im]Cl 0.1779 
[C4C1im]Br 0.1779 
[P4444]Cl  0.2206 
[C4C1im][CH3SO4] 0.2399 
[N4444]Cl 0.2586 
Na[SCN] 0.3129 
[C4C1im][SCN] 0.436 
[C4C1im][N(CN)2] 0.5091 
[C4C1im][CF3SO3] 0.5371 
Na[C7H5O2] 0.5669 
[C4C1im][TOS] 0.6766 
[C4C1py][N(CN)2] 0.7288 
 
The influence of the temperature on the solubility of CAF in IL aqueous solutions was also 
evaluated and is depicted in Figure 19. Correspondent data are reported in Appendix (cf. Appendix 
C - Table C 3). A well correlated increase of solubility of the alkaloid is accompanied by an 
increase in the temperature. This trend is consistent with a previous work, where a similar study 
was realized for the solutes vanillin and acid gallic [69]. This suggests that the effects of the IL 
concentration and temperature can be considered in order to improve the target solute solubilization 
performance, in this case, up to 6 times with [C4C1im]Cl in the temperature range studied. 
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Figure 18. Influence of the ILs concentration in the solubility of CAF in aqueous solutions of () 
[C4C1im][N(CN)2] and () [C4C1im]Cl at 303 K. Lines are guides for the eye. 
 
 
Figure 19. Temperature dependency for the solubility of CAF in aqueous solutions of [C4C1im]Cl at 0.1731 
mol·dm-3. 
 
Based on the previous results, the impact of the initial concentration of the solute (CAF) 
was evaluated. For that purpose, [CAF]IL and EECAF % were determined at different concentrations 
of CAF initially introduced into the system, and until the saturation of the solute has been reached, 
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in ABS composed of [C4C1im]Cl + K3[C6H5O7] + H2O and [C4C1im][N(CN)2] + K3[C6H5O7] + 
H2O. The partitioning experiments were carried out at the same initial mixture composition of 20 
wt % of salt and 40 wt % of IL. Figures 13 and 14 depict the EECAF % values obtained. Thus, for all 
the partitioning conditions, the pH values of the top and bottom phases, as well as the TL and TLL 
data, remain the same and are presented in Table 7.  
As CAF is intended to be almost extracted to the IL-rich phase in all ABS, Figure 20 
represents the influence of the initial concentration of CAF introduced in the system, in the 
solubility and extraction of CAF in the IL-rich phase. The experimental data of the partitioning of 
CAF are reported in Appendix (cf. Appendix D - Table D 4). It is possible to understand the 
hydrotropic ability of the IL to enhance the solubility of the solute in a ternary system. In general, 
for all the systems, an improved solubilization of CAF was observed, since [CAF]IL is higher than 
[CAF]initial, while the high EECAF % values were maintained. As also verified above, the ability of 
[C4C1im][N(CN)2] to act as hydrotrope is significantly higher than [C4C1im]Cl, due to better 
capability on enhancing the solubilization of higher concentrations of CAF.  
ILs show to have an enhanced hydrotropic ability by improving the solubilization of poorly 
water-soluble compounds. IL-based ABS are thus an alternative strategy, while it is possible to 
select the proper hydrotrope as well as to manipulate the TLL envisaging the optimization of the 
solubility of CAF in the IL-rich phase, and to better concentrate the pharmaceuticals that are found 
in trace amounts in wastewaters. Since the hydrotropic ability of ILs depend on the physico-
chemical properties of the solute, this is outstandingly advantageous to design extraction and 
concentration routes, while adding substantial value to the technology under development in this 
work. 
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Figure 20. Influence of the initial concentration of CAF, introduced in the system, [CAF]initial, in the 
solubility/extraction of CAF in the IL-rich phase of the ABS, composed of 20 wt% of 40 wt% of IL + 
K3[C6H5O7] + 40 wt% of H2O. [CAF]IL represents the concentration of CAF in the IL-rich phase for the ILs: 
() [C4C1im][N(CN)2] and () [C4C1im]Cl. EECAF % represents the percentage extraction efficiencies for 
the ILs: () [C4C1im][N(CN)2] and () [C4C1im]Cl. All the determinations were carried out at 298 K. 
 
3.5.  Conclusion 
ILs are a novel class of catanionic hydrotropes. In this work, it was investigated the 
hydrotropic mechanism of ILs applied to the alkaloid caffeine. In general, the higher the IL 
concentration, the higher is the ability of the IL to act as hydrotrope (although moving through a 
maximum), which is improved by an increase in temperature On the other hand, the salt 
K3[C6H5O7] used in the formulation of ABS acts a salting-out species. In summary, the TLL and 
KHyd of the IL allow a proper design of the system that leads to a better solubilization of the solute 
in the IL-rich phase, and  thus to better extraction and concentration approaches.  
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4.1.  Conclusions 
Due to the innumerous advantageous properties that ILs offer, IL-based ABS have been 
studied in the last years as alternative one-step extraction and concentration technologies for a wide 
plethora of compounds. In this thesis, the development of an analytical preconcentration 
technology for human pollution tracers from wastewater streams was investigated. In this context, 
this work was divided into two main sections: (i) the potential applicability of IL-based ABS to 
extract and concentrate pharmaceutical tracers from wastewaters; and (ii) the hydrotropic ability of 
ILs which enhance the solubility of poor-water soluble compounds in aqueous media. In the first 
part, by tuning the mixture point composition, it was possible to concentrate CAF and CBZ in the 
IL-rich phase, overcoming one of the major limitations in the analysis and monitoring of 
wastewaters, while allowing an evaluation of their environmental impact. However, further studies 
are still in need and are ongoing aiming at reaching higher concentration factors. Even so, these 
systems are straightforwardly envisaged for the one-step extraction and concentration of a large 
plethora of components currently present in wastewaters while overcoming one of the major 
challenges in the analytical field. In the second part, ILs as a novel class of catanionic hydrotropes, 
were investigated regarding their hydrotropic effect which could be reflected on the extraction and 
concentration ability of IL-based ABS. In summary, the TLL and KHyd of the IL allow a proper 
design of the system that leads to an enhanced solubilization of the solute in the IL-rich phase, 
allowing thus better extraction and concentration approaches.  
IL-based ABS are a promising and versatile alternative since they offer the opportunity to 
extract and concentrate (with a tailored ability) a variety of solutes present in trace amounts, in a 
single step, allowing therefore their proper identification and quantification in environmental 
matrices, such as surface waters, where a proper concentration of the compounds still is a main 
challenge. 
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4.2.  Future work 
In the future, the correct quantification of the TL applied in the concentration process is 
needed in order to achieve the high concentration factors initially established in this work. As 
demonstrated in previous studies, IL-based ABS are able to concentrate solutes from aqueous 
media up to 100- [42] and 1000-fold [48]. Therefore, only by attaining these values, this work 
would be comparable with the other processes already reported in the literature [76, 149-150, 155].  
Due to the high versatility and analyte-specificity associated to IL-based ABS, it would be 
interesting to continue the study of finding novel ABS. composed of ILs and other organic salts. 
and to study their potential applicability in the concentration of other micropollutants currently 
difficult to monitor in wastewaters. 
Finally, regarding the proposed technique, it would be of high value to test these systems 
with real water matrices, with different organic matter and ionic strength, aiming at providing their 
“real” applicability so that they could become a widespread applicable preconcentration technique 
in the near future.  
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A.1. NMR spectra 
The 
1
H NMR spectra of the pure potassium citrate used, from two different suppliers, were 
acquired in order to verify the presence of contaminants and are shown in Figures A 1 and A 2. 
 
Figure A 1. 1H NMR spectrum of the potassium citrate (K3[C6H5O7]), from Sigma-Aldrich, in DMSO. 
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Figure A 2. 1H NMR spectrum of the potassium citrate (K3[C6H5O7]), from GPR, in DMSO. 
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B.1. UV-Vis calibration curves for the pharmaceuticals 
Figures B 1 and B 2 depict the calibration curves (absorbance vs. concentration) of CAF 
and CBZ, using a Synergy|HT Microplate Reader, from Biotek, at 272 nm and 285 nm, 
respectively. Figures B 3 depicts the calibration curve (absorbance vs. concentration) using a 
SHIMADZU UV-1700, Pharma-Spec Spectrometer, at 274 nm. 
 
 
Figure B 1. Calibration curve for CAF, for Synergy|HT Microplate Reader, from Biotek, at λ = 272 nm. 
 
 
Figure B 2. Calibration curve for CBZ, for Synergy|HT Microplate Reader, from Biotek, at λ = 285 nm. 
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Figure B 3. Calibration curve for CAF, for UV-spectroscopy, using a SHIMADZU UV-1700, 
Pharma-Spec Spectrometer, at λ = 274 nm.
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C.1. Experimental data for the solubility of caffeine 
Table C 1 reports the concentration values of each hydrotrope studied, [Hyd], and the concentration values of CAF, [CAF], in aqueous solution 
of the corresponding hydrotrope. Table C 2 reports data relative to the influence of the ILs concentration on the solubility of CAF, (S/S0)CAF, in aqueous 
solutions of the corresponding ILs. Table C 3 reports the data corresponding to the temperature effect, T, on the solubility of CAF in aqueous solutions 
of the corresponding IL.  
 
Table C 1. Experimental solubility of caffeine in aqueous solutions of hydrotropes, at 303 K. 
Hydrotrope [Hyd] (mol·dm
-3
) [CAF] (mol·dm
-3
) [CAF] (g·dm
-3
) Hydrotrope [Hyd] (mol·dm
-3
) [CAF] (mol·dm
-3
) [CAF] (g·dm
-3
) 
H2O 0.00 0.00 23.09± 1.36 [C4C1im]Cl 1.01 0.14 27.49 ± 0.91 
[C4C1im]Br 0.24 0.14 26.36 ± 0.80  
1.43 0.14 26.28 ± 1.20 
 
0.51 0.15 29.52 ± 2.22 
 
2.45 0.17 33.62 ± 0.12 
 
0.81 0.17 32.20 ± 0.27 
 
5.73 0.14 26.65 ± 0.53 
 
1.14 0.18 35.88 ± 0.14 
 
51.53 0.03 6.03 ± 0.61 
[C4C1im][CF3SO3] 0.18 0.17 32.40 ± 0.44 [C4C1C1]imCl 0.59 0.14 28.01 ± 0.57 
 
0.39 0.22 43.06 ± 1.65 
 
1.32 0.21 40.31 ± 1.13 
 
0.62 0.26 49.89 ± 1.17 [C4C1py]Cl 0.60 0.14 27.63 ± 2.09 
 
0.87 0.32 61.53 ± 1.99 
 
1.35 0.15 28.51 ± 0.27 
[C4C1im][CH3SO4] 0.22 0.14 26.40 ± 0.25 [C4C1pyrr]Cl 0.63 0.11 22.48 ± 2.53 
 
0.44 0.15 28.53 ± 1.89 
 
1.41 0.10 19.86 ± 2.53 
 
0.70 0.18 34.48 ± 1.23 [C4C1pip]Cl 0.58 0.10 19.86 ± 4.27 
 
1.00 0.21 40.27 ± 2.57 
 
1.31 0.10 19.93 ± 0.97 
[C4C1im][TOS] 0.36 0.42 52.56 ±  1.36 [N1112OH]Cl 0.80 0.08 15.68 ± 0.40 
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0.80 0.69 71.74 ±  0.88 
 
1.79 0.06 11.78 ± 0.96 
[C4C1py][N(CN)2] 0.52 0.42 82.53 ± 2.05 [N4444]Cl 0.40 0.13 26.18 ± 0.62 
 
1.16 0.69 134.36 ± 1.65 
 
0.90 0.21 41.47 ± 1.42 
[C4C1im][SCN] 0.56 0.26 50.76 ± 3.38 [P4444]Cl 0.38 0.16 30.74 ± 1.87 
 
1.27 0.39 74.94 ± 5.16 
 
0.85 0.18 34.07 ± 3.97 
[C4C1im][N(CN)2] 0.26 0.19 36.37 ± 0.88 Na3[C6H5O7] 0.43 0.05 9.01 ± 2.07 
 
0.54 0.27 51.52 ± 2.02 
 
0.97 0.02 3.51 ± 0.36 
 
0.86 0.35 67.69 ± 0.69 Na[C7H5O2] 0.78 0.57 109.78 ± 1.27 
 
1.22 0.43 82.96 ± 1.17 
 
1.74 0.90 175.28 ± 1.49 
 
4.88 0.45 87.87 ± 2.65 Na[SCN] 1.38 0.41 79.39 ± 2.60 
 
14.61 0.27 52.69 ± 0.73 
 
3.08 0.99 191.37 ± 6.95 
 
48713.83 0.13 25.99 ± 2.67 K3[C6H5O7] 0.36 0.05 9.33 ± 0.31 
[C4C1im]Cl 0.30 0.13 24.81 ± 1.36  
0.82 0.03 5.12 ± 0.03 
 
0.63 0.13 25.67 ± 1.20 
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Table C 2. Data relative to the influence of the ILs concentration in the solubility, S/S0, of CAF in aqueous 
solutions of [C4C1im][N(CN)2] and [C4C1im]Cl. 
Hydrotrope [Hyd] (mol·dm
-3
) (S/S0)CAF 
[C4C1im][N(CN)2] 
0.00 1.00 
0.25 1.58 
0.49 2.23 
0.73 2.93 
0.98 3.59 
2.44 3.81 
3.65 2.28 
4.87 1.13 
[C4C1im]Cl 
0.00 1.00 
0.28 1.07 
0.57 1.11 
0.86 1.19 
1.72 1.46 
2.86 1.15 
5.15 0.26 
 
Table C 3. Data relative to the temperature, T, dependency of the concentration of CAF (solubility) in 
aqueous solutions of [C4C1im]Cl at 0.1731 mol·kg
-1 and respective standard deviations. 
T (K) [CAF] ± σ (mol·dm-3) 
288 0.070 ± 0.001 
303 0.173 ± 0.001 
318 0.287 ± 0.002 
333 0.396 ± 0.015 
343 0.477 ± 0.039 
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D.1. Speciation data of the pharmaceuticals 
In Figures D 1 and D 2 are presented the effect of the pH in the concentration of different species that can exist in aqueous solutions of CAF and 
CBZ, respectively. 
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Figure D 1. Speciation diagram of CAF [1]. Figure D 2. Speciation diagram of CBZ [1]. 
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D.2. Extraction data for the pharmaceuticals 
Tables D 1 and D 2 present the concentration factors, composition of the phases and the 
recovery of caffeine determined by HPLC – UV-Vis.  
Tables D 3 and D 4 present the initial mixture compositions, and respective TLLs, and the 
partition coefficients of the different pharmaceuticals. 
 
Table D 1. Mixture compositions, weight percentages of the IL- and salt-rich phases obtained by the lever-
arm rule and respective estimated concentration factor, CF, for the [N4444]Cl + K3[C6H5O7] + H2O ABS. The 
TL used here was analytically quantified (TLL ≈ 79). The parameters of the TL equation are: slope = -1.28 
and y-intercept = 64.96. 
Weight fraction composition (wt %) 
CF 
[IL]M [salt]M [water]M [IL-rich phase] [salt-rich phase] 
62.20 2.16 35.65 100.00 0.00 0.36 
48.71 12.70 38.59 77.90 22.10 0.50 
26.58 30.00 43.42 41.64 58.36 1.04 
6.95 45.34 47.71 9.49 90.51 5.02 
4.10 47.57 48.33 4.82 95.18 10.03 
1.45 49.64 48.91 0.48 99.52 101.46 
1.18 49.85 48.97 0.05 99.95 1061.99 
1.16 49.87 48.97 0.00 100.00 N.D.a 
a
 N.D. not determined 
 
Table D 2. Chromatographic data for the quantification of CAF and CBZ, including the retention time, 
tretention, peak area, Apeak, and percentage recoveries with the respective standard deviation values. 
System Pharmaceutical tretention (min) Apeak % Recovery ± σ CF 
Single 
extraction 
CAF 3.74 48973 98 ± (---)a 45.88 
Single 
extraction 
CBZ 11.33 29847 125 ± (---) 47.39 
Simultaneous  
extraction 
CAF 3.6915 88955 91 ± 15 
48.97 
CBZ 8.7845 33037 104 ± 5 
Blank control (---) (---) (---) (---) 53.39 
a (---) these values were not determined during the experimental procedure 
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Table D 3. Extraction efficiencies of CAF (EECAF%) in IL + K3[C6H5O7] + H2O ABS, and respective 
standard deviations, mixture compositions, and TLL values. 
IL 
Weight fraction 
composition (wt %) 
TLL 
EECAF % ± σ 
EECBZ % ± 
σ 
[IL]M [Salt]M 
0.912 g·dm-
3
 CAF 
0.456 g·dm-3 
CAF 
0.228 g·dm-3 
CAF 
[C4C1im][CF3SO3] 40.54 18.96 90.04 96.57 ± 0.03 (---)
a (---) 99.92 ± 0.02 
[C4C1im][N(CN)2] 39.81 20.12 92.87 99.18 ± 0.13 (---) (---) (---) 
[C4C1im][SCN] 39.57 19.94 83.68 98.68 ± 0.04 (---) (---) 99.97 ± 0.01 
[C4C1im]Br 
39.22 20.15 74.73 97.56 ± 0.36 97.49 ± 0.04 97.32 ± 0.18 99.83 ± 0.05 
40.01 22.36 81.99 98.09 ± 0.07 97.79 ± 0.17 97.15 ± 0.13 (---) 
39.47 25.22 87.93 98.65 ± 0.13 97.81 ± 0.18 96.79 ± 0.32 (---) 
41.77 25.07 91.46 98.95 ± 0.17 98.17 ± 0.25 98.05 ± 0.21 (---) 
44.74 24.97 95.63 99.68 ± 0.03 100.00 ± 0.20 100.00 ± 0.20 (---) 
[C4C1im]Cl 39.34 20.05 62.97 98.5 ± 0.04 (---) (---) 99.64 ± 0.06 
[N4444]Cl 40.06 20.07 78.85 99.61 ± 0.16 (---) (---) (---) 
[P4444]Cl 39.54 20.02 75.34 99.59 ± 0.09 (---) (---) (---) 
[C4C1pyr]Cl 40.01 19.97 71.71 98.88 ± 0.05 (---) (---) (---) 
[C4C1pip]Cl 39.73 20.06 74.99 95.21 ± 0.20 (---) (---) (---) 
[C4C1C1im]Cl 36.35 23.24 48.98 98.57 ± 0.36 (---) (---) 99.25 ± 0.09 
a (---) values not determined during the experimental procedure 
 
Table D 4. Extraction efficiencies of CAF (EECAF%) in IL + K3[C6H5O7] + H2O ABS, and respective 
standard deviations, mixture compositions, and concentration values of CAF initially added in the ABS 
([CAF]ABS) and in the IL-rich phase ([CAF]IL). 
IL 
Weight fraction composition 
(wt %) [CAF]ABS 
(mol·dm
-3
) 
[CAF]IL 
(mol·dm
-3
) 
EECAF % ± σ 
[IL]M [Salt]M 
[C4C1im][N(CN)2]  39.81 20.12 
0.0051 0.0015 99.18 ± 0.13 
0.0515 0.0865 98.92 ± 0.19 
0.1287 0.2559 99.49 ± 0.04 
0.2575 0.3796 99.37 ± 0.06 
[C4C1im]Cl  39.34 20.05 
0.0051 0.0014 97.56 ± 0.36 
0.0515 0.0504 98.38 ± 0.13 
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